CDC at Work: Mycotic Diseases Branch

On This Page

About Us
Mycotic Diseases Branch Teams
Fungal Disease Outbreaks
International Activities
Publications

CDC’s lead group for preventing illness and death from fungal diseases in the United States and throughout the world.

About Us

The goal of CDC’s Mycotic Diseases Branch (MDB) is to prevent illness and death from fungal diseases. We are one of few public health groups in the world devoted to the prevention and control of fungal diseases. We work with partners to understand who gets fungal infections and why they get them by using epidemiology and microbiology research. We also investigate outbreaks and develop interventions to prevent fungal diseases.

Why fungal diseases are a public health problem: [PDF – 2 pages]:

Increasing number of people with weakened immune systems. Opportunistic infections such as cryptococcosis and aspergillosis affect cancer patients, organ transplant recipients, and people with HIV.
Advancements and changes in healthcare practices. Healthcare-associated infections such as candidemia are a major concern in the United States. Advancements and changes in healthcare practices can allow new and drug-resistant fungi to emerge in healthcare settings.
Changes in the environment. Fungi that live in soil or other parts of the natural environment cause diseases such as coccidioidomycosis (Valley fever) and histoplasmosis. Weather and climate changes may be affecting these types of fungi.

Learn more about why fungal diseases are a public health problem [PDF – 2 pages].

Mycotic Diseases Branch Teams

Our teams work together, along with domestic and international partners, to combat fungal diseases in the following ways:

Generate new information about fungal diseases and disease-causing fungi.
Respond quickly to fungal disease outbreaks and other emerging issues.
Conduct research.
Provide training and education about fungal diseases.

Epidemiology Team

Our epidemiologists:

Calculate the number of people who get sick from fungal diseases.
Track trends and patterns in how fungal diseases affect people.
Promote education and awareness about fungal diseases.
Develop and evaluate ways to prevent fungal diseases.
Help prepare healthcare facilities and laboratories in other countries to better detect and treat fungal diseases.

A woman reviewing a chart labeled, 'Mold Surveillance System Diagram'

Laboratory Team

Our laboratory staff:

Find and identify disease-causing fungi in patient and environmental specimens (laboratories: see specimen submission information for details).
Perform tests on certain specimens to see if they are resistant to antifungal medicines.
Research and develop new detection, diagnostic, and subtyping methods.
Use whole genome sequencing to study how and why certain fungi spread and make people sick.
Conduct a yearly mold identification training course in collaboration with the Association of Public Health Laboratories.
Help other domestic and international laboratories improve their abilities to test for certain fungi.

A scientist looking at a fungus sample through a microscope.

Data and Quality Team

Our data and quality staff:

Comprise a group with diverse professional backgrounds who work at the intersection of laboratory science and epidemiology. Staff includes bioinformaticians, data scientists, laboratorians, and epidemiologists.
Track the emergence and spread of fungal diseases by conducting molecular surveillance and genomic epidemiology.
Advance the use of genomics and metagenomics for detecting fungal pathogens and antifungal drug resistance.
Build data systems that link various data sources and allow for automated, more efficient data analysis and visualization.
Develop and implement quality management systems that promote data accuracy, consistent testing, safety, and efficient processes.

Fungal Disease Outbreaks

Fungal disease outbreaks are rare. An outbreak occurs when two or more people get sick from contact with the same source, sometimes in the same time or place. This can happen outdoors or in a health care setting, such as a hospital.

Detecting fungal outbreaks early is important so that the people affected can get the right treatment and so that health officials can prevent others from getting sick.

Learn more about fungal disease outbreaks.

Top of Page

International Activities

Many people at risk for and suffering from fungal diseases live in limited-resource settings. These areas of the world often lack the laboratory infrastructure needed to diagnose fungal diseases, and limited availability of antifungal medications means that some patients may not have access to lifesaving treatments. CDC is working with partners to improve access to fungal diagnostics and antifungal medications around the globe.

Learn more about some fungal diseases in low-resource settings:

Top of Page

Publications

Sharing scientific findings is an important part of the prevention and control of fungal diseases. Our branch is involved in producing numerous articles and papers that detail our research findings and investigations and provide reviews on important fungal topics.

Key Publications by Year

Yasinskaya Y, Bala S, Waack U, Dixon C, Higgins K, Moore JN, et al. Food and Drug Administration Public Workshop Summary-Development Considerations of Antifungal Drugs to Address Unmet Medical Need. Clin Infect Dis. 2023 Apr 6.
Gold JAW, Benedict K, Lockhart SR, Lipner SR. Epidemiology of tinea capitis causative species: an analysis of fungal culture results from a major U.S. national commercial laboratory. J Am Acad Dermatol. 2023 Mar 30.
Segaloff HE, Wu K, Shaw S, Klasen EM, Peterson L, Lindberg S, et al. Notes from the Field: Cluster of Blastomycosis Among Neighborhood Residents – St. Croix County, Wisconsin, 2022. MMWR Morb Mortal Wkly Rep. 2023 Mar 31.
Benedict K, Baggs J, Wolford H, Jackson BR, Gold JAW. Hospitalizations for Unspecified Mycoses in a Large Administrative Data Set and Implications for Fungal Disease Burden Estimates, United States, 2019-2021. Open Forum Infect Dis. 2023 Feb 24
Oladele RO, Jordan AM, Okaa JU, Osaigbovo II, Shettima SA, Shehu NY, et al. A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria. PLOS Glob Public Health. 2023 Jan 31.
Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, Chiller T. Worsening Spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 2023 Mar 21.
de Barros Rodrigues DK, Lockhart SR, Berkow EL, Gade L, Bonfietti LX, Mazo Fávero Gimenes V, et al. Whole-genome sequencing of Candida haemulonii species complex from Brazil and the United States: Genetic diversity and antifungal susceptibility. Med Mycol. 2023 Apr 3
Benedict K, Jackson BR, Toda M. Diagnosis codes for mold infections and mold exposure before and after Hurricane Harvey among a commercially insured population-Houston, Texas, 2016-2018. Disaster Med Public Health Prep. 2023 Mar 17.
Toda M, Williams S, Jackson BR, Wurster S, Serpa JA, Nigo M, et al. Invasive Mold Infections Following Hurricane Harvey-Houston, Texas. Open Forum Infect Dis. 2023 Feb 21.
Oboho IK, Paulin H, Corcoran C, Hamilton M, Jordan A, Kirking HL, et al. Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries. J Int AIDS Soc. 2023 Mar.
Gold JAW, Benedict K, Dulski TM, Lipner SR. Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States. J Am Acad Dermatol. 2023 Feb 15.
Misas E, Deng JZ, Gold JAW, Gade L, Nunnally NS, Georgacopoulos O, et al. Genomic description of human clinical Aspergillus fumigatus isolates, California, 2020. Med Mycol. 2023 Feb 3.
Tharp B, Zheng R, Bryak G, Litvintseva AP, Hayden MK, Chowdhary A, et al. Role of Microbiota in the Skin Colonization of Candida auris. mSphere. 2023 Feb 21.
Georgacopoulos O, Nunnally N, Law D, Birch M, Berkow EL, Lockhart SR. In Vitro Activity of the Novel Antifungal Olorofim against Scedosporium and Lomentospora prolificans. Microbiol Spectr. 2023 Feb 14.
Pasqualotto AC, Queiroz-Telles F, Chebabo A, Leitao TMJS, Falci DR, Xavier MO, et al. The “Histoplasmosis Porto Alegre manifesto”-Addressing disseminated histoplasmosis in AIDS. PLoS Negl Trop Dis. 2023 Jan 5.
Monroy-Nieto J, Gade L, Benedict K, Etienne KA, Litvintseva AP, Bowers JR, et al. Genomic Epidemiology Linking Nonendemic Coccidioidomycosis to Travel. Emerg Infect Dis. 2023 Jan.
Waters A, Chommanard C, Baltozer S, Angel LC, Abdelfattah R, Lyman M, et al. Investigation of a Candida auris outbreak in a skilled nursing facility – Virginia, United States, October 2020-June 2021. Am J Infect Control. 2023 Apr.
Shapiro AE, Tenforde MW, Chiller TM, Ford N, Rajasingham R. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies. HIV Med. 2023 Apr.
Gold JAW, Wu K, Jackson BR, Benedict K. Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States. J Am Acad Dermatol. 2023 Mar.
Gold JAW, Ahmad FB, Cisewski JA, Rossen LM, Montero AJ, Benedict K, et al. Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic-National Vital Statistics System, United States, January 2020-December 2021. Clin Infect Dis. 2023 Feb 8.

Bagal UR, Ireland M, Gross A, Fischer J, Bentz M, Berkow EL, et al. Molecular Epidemiology of Blastomyces gilchristii Clusters, Minnesota, USA. Emerg Infect Dis. 2022 Sep.
Gow NAR, Johnson C, Berman J, Coste AT, Cuomo CA, Perlin DS, et al. The importance of antimicrobial resistance in medical mycology. Nat Commun. 2022 Sep 12.
Williams SL, Chiller T. Update on the Epidemiology, Diagnosis, and Treatment of Coccidioidomycosis. J Fungi (Basel). 2022 Jun 25.
Benedict K, Gold JAW, Dietz S, Anjum S, Williamson PR, Jackson BR. Testing for Cryptococcosis at a Major Commercial Laboratory-United States, 2019-2021. Open Forum Infect Dis. 2022 May 16.
Caceres DH, Lindsley MD. Comparison of Immunodiagnostic Assays for the Rapid Diagnosis of Coccidioidomycosis in Dogs. J Fungi (Basel). 2022 Jul 13.
Bradley K, Le-Mahajan A, Morris B, Peritz T, Chiller T, Forsberg K, et al. Fatal Fungicide-Associated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA. Emerg Infect Dis. 2022 Sep.
Smith DJ, Williams SL; Endemic Mycoses State Partners Group, Benedict KM, Jackson BR, Toda M. Surveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis – United States, 2019. MMWR Surveill Summ. 2022 Aug 19.
Litvintseva AP, Chow NA, Salah Z. The Association between Coccidioides immitis and Rodent Habitats in Washington State Remains Unresolved. mSphere. 2022 Aug 31.
Glowicz J, Benowitz I, Arduino MJ, Li R, Wu K, Jordan A, et al. Keeping health care linens clean: Underrecognized hazards and critical control points to avoid contamination of laundered health care textiles. Am J Infect Control. 2022 Oct.
Gold JAW, Tolu SS, Chiller T, Benedict K, Jackson BR. Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and Other Small Molecule Kinase Inhibitors-United States, July 2016-June 2019. Clin Infect Dis. 2022 Aug 25.
Gandhi P, Benedict K, Toda M, Beer KD, Chiller TM, Jackson BR. Patient notification about suspected hospital-associated outbreaks of invasive mold infections: Considerations for public health and hospital personnel – CORRIGENDUM. Infect Control Hosp Epidemiol. 2022 Sep.
Gold JAW, Wu K, Jackson BR, Benedict K. Opportunities to improve guideline adherence for the diagnosis and treatment of onychomycosis: Analysis of commercial insurance claims data, United States. J Am Acad Dermatol. 2022 Jul 7.
González-Durán E, Contreras-Pérez CU, Caceres DH, Ríos-Rosas C, Piñón-Ortega JJ, Téllez-Saucedo MD, et al. The use of readily available laboratory tests for the identification of the emerging yeast Candida auris in Mexico. Arch Microbiol. 2022 Sep 2.
Caceres DH, Echeverri Tirado LC, Bonifaz A, Adenis A, Gomez BL, Flores CLB, et al. Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA). Mycoses. 2022 Jul 30.
Cognialli R, Bloss K, Weiss I, Caceres DH, Davis R, Queiroz-Telles F. A lateral flow assay for the immunodiagnosis of human cat-transmitted sporotrichosis. Mycoses. 2022 Oct.
Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022 Aug 29.
Gómez LF, Gade L, Litvintseva AP, McEwen JG, Peláez CA, Arango M, et al. Comparison between Two Molecular Techniques: Nested and Real-Time Polymerase Chain Reaction Targeting 100-kDa Hc Protein for Detection of Histoplasma capsulatum in Environmental Samples. Am J Trop Med Hyg. 2022 Mar 14.
Shapiro AE, Tenforde MW, Chiller TM, Ford N, Rajasingham R. An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies. HIV Med. 2022 Sep 19.
Benedict K, Wu K, Gold JAW. Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea-United States, 2022. J Fungi (Basel). 2022 Aug 9.
Meletiadis J, Andes DR, Lockhart SR, Ghannoum MA, Knapp CC, Ostrosky-Zeichner L, et al. Multicenter Collaborative Study of the Interaction of Antifungal Combinations against Candida Spp. by Loewe Additivity and Bliss Independence-Based Response Surface Analysis. J Fungi (Basel). 2022 Sep 16.
de Groot T, Spruijtenburg B, Parnell LA, Chow NA, Meis JF. Optimization and Validation of Candida auris Short Tandem Repeat Analysis. Microbiol Spectr. 2022 Oct 3.
Langfeldt A, Gold JAW, Chiller T. Emerging Fungal Infections: from the Fields to the Clinic, Resistant Aspergillus fumigatus and Dermatophyte Species: a One Health Perspective on an Urgent Public Health Problem. Curr Clin Microbiol Rep. 2022 Sep 27.
Lockhart SR, Lyman MM, Sexton DJ. Tools for detecting a “superbug”: updates on Candida auris testing. Journal of Clinical Microbiology. 2022 Jan 5.
Escandón P, Cáceres DH, Lizarazo D, Lockhart SR, Lyman M, Duarte C. Laboratory-based surveillance of Candida auris in Colombia, 2016-2020. Mycoses. 2022 Feb.
Benedict K, Whitham HK, Jackson BR. Economic Burden of Fungal Diseases in the United States. Open Forum Infect Dis. 2022 Mar 23.
Cáceres DH, Gómez BL, Tobón ÁM, Chiller TM, Lindsley MD. Evaluation of OIDx Histoplasma Urinary Antigen EIA. Mycopathologia. 2022 Feb.
Benedict K, Singleton AL, Jackson BR, Molinari NAM. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020. BMC Womens Health. 2022 May 10.
Gandhi P, Malone L, Williams S, Hall C, Short K, Benedict K, et al. Perceptions, knowledge, and communication preferences about indoor mold and its health implications among persons affected by Hurricane Harvey: a focus group analysis. BMC Public Health. 2022 Jun 15.
Gold JAW, Ahmad FB, Cisewski JA, Rossen LM, Montero AJ, Benedict K, et al. Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021. Clin Infect Dis. 2022 Jun 19.
Larson B, Shroufi A, Muthoga C, Oladele R, Rajasingham R, Jordan A, et al. Induction-phase treatment costs for cryptococcal meningitis in high HIV-burden African countries: New opportunities with lower costs. Wellcome Open Res. 2022 Mar 29.
Seagle EE, Jackson BR, Lockhart SR, Georgacopoulos O, Nunnally NS, Roland J, et al. The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic. Clin Infect Dis. 2022 Mar 9.
Hepler SA, Kaufeld KA, Benedict K, Toda M, Jackson BR, Liu X, et al. Integrating Public Health Surveillance and Environmental Data to Model Presence of Histoplasma in the United States. Epidemiology. 2022 May 5.
Wurster S, Paraskevopoulos T, Toda M, Jiang Y, Tarrand JJ, Williams S, et al. Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey – a closer look at an immunocompromised cancer patient population. J Infect. 2022 May.
Castelo-Branco D, Lockhart SR, Chen YC, Santos DA, Hagen F, Hawkins NJ, et al. Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance. Mycoses. 2022 Mar.
Benedict K, Lyman M, Jackson BR. Possible misdiagnosis, inappropriate empiric treatment, and opportunities for increased diagnostic testing for patients with vulvovaginal candidiasis-United States, 2018. PLoS One. 2022 Apr 28.
Bagal UR, Phan J, Welsh RM, Misas E, Wagner D, Gade L, et al. MycoSNP: A Portable Workflow for Performing Whole-Genome Sequencing Analysis of Candida auris. Methods Mol Biol. 2022.
Gold JAW, Revis A, Thomas S, Perry L, Blakney RA, Chambers T, et al. Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019. Open Forum Infect Dis. 2022 Apr 21.

Karmarkar E, O’Donnell K, Prestel C, Forsberg K, Gade L, Jain S, et al. Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019. Annals of Internal Medicine. 2021 September 7.
Torres Fuentes CE, Rodríguez Mantilla IE, Cáceres DNG, Camargo Gonzalez DF. Red Blood Cell Transfusion and its Relationship with Pedicle Thrombosis in Microvascular Free Flaps. Journal of Reconstructive Microsurgery. 2021 September 2.
Wanga V, Chevinsky JR, Dimitrov LV, Gerdes ME, Whitfield GP, Bonacci RA, et al. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 – United States, January 2020-April 2021. MMWR Morbidity and Mortality Weekly Report. 2021 September 10.
Forno D, Samayoa B, Medina N, Arathoon E, Mejia CR, Gordillo R, et al. Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador. Mycoses. 2021 September 18.
Cáceres DH, Gómez BL, Tobón ÁM, Minderman M, Bridges N, Chiller T, et al. Validation and Concordance Analysis of a New Lateral Flow Assay for Detection of Histoplasma Antigen in Urine. Journal of Fungi. 2021 September 24.
Leinert JL, Weichert S, Jordan AJ, Adam R. Non-Typhoidal Salmonella Infection in Children: Influence of Antibiotic Therapy on Postconvalescent Excretion and Clinical Course-A Systematic Review. Antibiotics (Basel). 2021 September 29.
Jordan A, Sivapalan P, Eklöf, J, Vestergaard JB, Meteran H, Saeed MI, et al. The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD-A Nationwide Cohort Study of 49,500 Patients. Biomedicines. 2021 October 18.
Mak G, Lau S, Wong K, Chow N, Lau CS, Lam E, et al. Comparison of analytical sensitivity of the eight rapid antigen detection kits for detecting SARS-CoV-2 virus. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2021 October 2.
Tinker SC, Szablewski CM, Litvintseva AP, Drenzek C, Voccio GE, Hunter MA, et al. Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students. Emerging Infectious Diseases. 2021 October.
scandón P, Cáceres DH, Lizarazo D, Lockhart SR, Lyman M, Duarte C. Laboratory-based surveillance of Candida auris in Colombia, 2016-2020. Mycoses. 2021 Nov 3
Chow NA, Kangiser D, Gade L, McCotter OZ, Hurst S, Salamone A, et al. Factors Influencing Distribution of Coccidioides immitis in Soil, Washington State, 2016. mSphere. 2021 Nov 3.
Castelo-Branco D, Lockhart SR, Chen YC, Santos DA, Hagen F, Hawkins NK, et al. Collateral consequences of agricultural fungicides on pathogenic yeasts: a One Health perspective to tackle azole resistance. Mycoses. 2021 Nov 25.
Cáceres DH, Gómez BL, Tobón ÁM, Chiller TM, Lindsley MD. Evaluation of OIDx Histoplasma Urinary Antigen EIA. Mycopathologia. 2021 Nov 20.
Arastehfar A, Marcet-Houben M, Daneshnia F, Taj-Aldeen SJ, Batra D, Lockhart SR, et al. Comparative genomic analysis of clinical Candida glabrata isolates identifies multiple polymorphic loci that can improve existing multilocus sequence typing strategy. Studies in Mycology. 2021 September.
Benedict K, Tsay S, Bartoces M, Vallabhaneni S, Jackson B, Hicks L. Outpatient antifungal prescribing patterns in the United States, 2018. Antimicrobial Stewardship & Healthcare Epidemiology. 2021 December 22.
Karmarkar E, Lyman M, Jackson BR. Candida auris: Coming Soon to a Facility Near You. Contagion. 2021 December 21
Gold JAW, Tolu SS, Chiller T, Benedict K, Jackson BR. Incidence of Invasive Fungal Infections in Patients Initiating Ibrutinib and other Small Molecule Kinase Inhibitors – United States, July 2016-June 2019. Clinical Infectious Disease. 2021 Dec 10
Baddley JW, Thompson GR 3rd, Chen SC, White PL, Johnson MD, Nguyen MH, et al. Coronavirus Disease 2019-Associated Invasive Fungal Infection. Open Forum Infectious Diseases. 2021 Nov 16
Gandhi P, Benedict K, Toda M, Beer KD, Chiller TM, Jackson BR. Patient notification about suspected hospital-associated outbreaks of invasive mold infections: Considerations for public health and hospital personnel – CORRIGENDUM. Infection Control and Hospital Epidemiology. 2021 Nov 12
Yang DH, England MR, Salvator H, Anjum S, Park YD, Marr KA, et all. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection. mBio. 2021 Oct 26
Narayanasamy S, Dat VQ, Thanh NT, Ly VT, Chan JF, Yuen KY, et al. A global call for talaromycosis to be recognised as a neglected tropical disease. Lancet Glob Health. 2021 Nov.
Al Dallal HA, Narayanan S, Jones CM, Lockhart SR, Snyder JW. First Case Report of an Unusual Fungus (Sporopachydermia lactativora) Associated with a Pulmonary Infection in a Drug Injection User. Clinical Pathology. 2021 Jul 12
Baddley JW, Chen SC, Huisingh C, Benedict K, DeBess EE, Galanis E, et al. MSG07: An International Cohort Study Comparing Epidemiology and Outcomes of Patients with Cryptococcus neoformans or Cryptococcus gattii infections. Clin Infect Dis. 2021 Mar 27
Benedict K, Li Y, Molinari NAM, Jackson BR. Healthcare Providers’ Testing Practices for Coccidioidomycosis and Histoplasmosis in Patients with Community-Acquired Pneumonia – United States, 2020. Open Forum Infectious Diseases. 2021 Jan 18
Benedict K, Williams S, Beekmann SE, Polgreen PM, Jackson BR, Toda M. Testing Practices for Fungal Respiratory Infections and SARS-CoV-2 among Infectious Disease Specialists, United States. Journal of Fungi. 2021 Jul 27.
Bentz ML, Nunnally N, Lockhart SR, Sexton DJ, Berkow EL. Antifungal activity of nikkomycin Z against Candida auris. J Antimicrob Chemother. 2021 Mar 3
Benedict K, Toda M, Jackson BR. Revising conventional wisdom about histoplasmosis in the United States. Open Forum Infectious Diseases. 2021 Jun 10
Bentz ML, Nunnally N, Lockhart SR, Sexton DJ, Berkow EL. Antifungal activity of nikkomycin Z against Candida auris. J Antimicrob Chemother. 2021 Mar 3
Caceres DH, Arauz AB, Flores C, Santiago E, Montoya S, Carlos Saenz, et al. Implementation of Rapid Diagnostics Assays for Detection of Histoplasmosis and Cryptococcosis in Central American People Living with HIV. Mycoses: Diagnosis, Therapy, and Prophylaxis of Fungal Diseases. 2021 May 9
Carey A, Gorris ME, Chiller T, Jackson B, Beadles W, Webb BJ. Epidemiology, Clinical Features, and Outcomes of Coccidioidomycosis, Utah, 2006-2015. Emerging Infectious Diseases. 2021 September.
de Perio MA, Benedict K, Williams SL, Niemeier-Walsh C, Green BJ, Coffey C, et al. Occupational Histoplasmosis: Epidemiology and Prevention Measures. J Fungi (Basel). 2021 Jun 26
Dobos RR, Benedict K, Jackson BR, McCotter OZ. Using soil survey data to model potential Coccidioides soil habitat and inform Valley fever epidemiology. PLOS ONE. 2021 Feb 19
Etienne KA, Berkow EL, Gade L, Nunnally N, Lockhart SR, Beer K, et al. Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States. mBio. 2021 Aug 10.
Gandhi P, Benedict K, Toda M, Beer KD, Chiller TM, Jackson BR. Patient notification about suspected hospital-associated outbreaks of invasive mold infections: Considerations for public health and hospital personnel. Infect Control Hosp Epidemiol. 2021 Jun 10
Gavilanes‐Martínez MA, Garzón AC, Cáceres DH, and García AM. Antifungal Activity of Boric Acid, Triclosan and Zinc Oxide Against Different Clinically Relevant Candida Species. Mycoses: Diagnosis, Therapy, and Prophylaxis of Fungal Diseases. 2021 May 10
Georgacopoulos O, Nunnally NS, Ransom EM, Law D, Birch M, Lockhart SR, et al. In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents. J Fungi (Basel). 2021 May 12
Gold JAW, Jackson BR, Glowicz J, Mead KR, Beer KD. Surveillance practices and air-sampling strategies to address healthcare-associated invasive mold infections in Society for Healthcare Epidemiology of America (SHEA) Research Network hospitals-United States, 2020. Infect Control Hosp Epidemiol. 2021 Jul 16
Gold JAW, Kiernan E, Yeh M, Jackson BR, Benedict K. Health Care Utilization and Outcomes Associated with Accidental Poisonous Mushroom Ingestions – United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 2021 Mar 12
Gold JAW, Seagle EE, Nadle J, Barter DM, Czaja CA, Johnston H, et al. Treatment Practices for Adults with Candidemia at Nine Active Surveillance Sites – United States, 2017-2018. Clin Infect Dis. 2021 Jun 3
Huang X, Welsh RM, Deming C, Proctor DM, Thomas PJ, NISC Comparative Sequencing Program, et al. Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes. mSphere. 2021 Aug 4.
Izco S, Murias-Closas A, Jordan AM, Greene G, Catorze N, Chiconela H, et al. Improved Detection and Management of Advanced HIV Disease Through A Community Adult TB-Contact Tracing Intervention with Same-Day Provision of the WHO-Recommended Package of Care Including ART Initiation in a Rural District of Mozambique. Journal of the International AIDS Society. 2021 Aug 4
Kanwar A, Jordan A, Olewiler S, Wehberg K, Cortes M, Jackson BR. A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19. Journal of Fungi. 2021 Feb 28
Karmarkar E, O’Donnell K, Prestel C, Forsberg K, Gade L, Jain S, et al. Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings—Orange County, California, 2019. Annals of Internal Medicine. 2021 September 7.
Lockhart SR, Bialek R, Kibbler CC, Cuenca-Estrella M, Jensen HE, Kontoyiannis DP. Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. Clin Infect Dis. 2021 Mar 12
Lockhart SR, Toda M, Benedict K, Caceres DH, Litvintseva AP. Endemic and Other Dimorphic Mycoses in the Americas. Journal of Fungi. 2021
Lyman M, Forsberg K, Reuben J, Dang T, Free R, Seagle EE, et al. Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities – Texas and the District of Columbia, January-April 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23
Lysen C, Silva-Flannery L, Zaki SR, Gary JM, Lockhart SR. Performance evaluation of fungal DNA PCR amplification from formalin-fixed paraffin-embedded tissue for diagnosis; experience of a tertiary reference laboratory. Mycoses. 2021 Feb 2
Naicker SD, Maphanga TG, Chow NA, Allam M, Kwenda S, Ismail A, et al. Clade distribution of Candida auris in South Africa using whole genome sequencing of clinical and environmental isolates. Emerg Microbes Infect. 2021 Jun 28
Natarajan P, Lockhart SR, Basavaraju SV, Anjan S, Lindsley MD, McGrath MM, et al. Donor-derived Cryptococcus gattii sensu stricto infection in two kidney transplant recipients, southeastern United States. Am J Transplant. 2021 Jun 26
Nunnally NS, Damm T, Lockhart SR, Berkow EL. Categorizing susceptibility of clinical isolates of Candida auris to amphotericin B, caspofungin, and fluconazole utilizing the CLSI M44-A2 disk diffusion method. J Clin Microbiol. 2021 Jan 6
Perez F, Caceres DH, Ford N, Ravasi G, Gomez BL, Pasqualotto AC, et al. Summary of Guidelines for Managing Histoplasmosis among People Living with HIV. J Fungi (Basel). 2021 Feb 12
Prestel C, Anderson E, Forsberg K, Lyman M, de Perio MA, Kuhar D, et al. Candida auris outbreak in a COVID-19 specialty care unit — Florida, July–August 2020. MMWR. 2021 Jan 8
Proctor DM, Dangana T, Sexton DJ, Fukuda C, Yelin RD, Stanley M, et al. Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facility. Nat Med. 2021 Jun 21
Seagle EE, Jackson BR, Lockhart SR, Georgacopoulos O, Nunnally NS, Roland J, et al. The landscape of candidemia during the COVID-19 pandemic. Clin Infect Dis. 2021 Jun 18.
Seagle EE, Williams SL, Chiller TM. Recent Trends in the Epidemiology of Fungal Infections. Infect Dis Clin North Am. 2021 Jun
Sexton DJ, Bentz ML, Welsh RM, Derado G, Furin W, Rose LJ, et al. Positive correlation between Candida auris skin-colonization burden and environmental contamination at a ventilator-capable skilled nursing facility in Chicago. Clin Infect Dis. 2021 May 12
Toda M, Beer KD, Kuivila KM, Chiller TM, Jackson BR. Trends in Agricultural Triazole Fungicide Use in the United States, 1992-2016 and Possible Implications for Antifungal-Resistant Fungi in Human Disease. Environ Health Perspect. 2021 May 5
Toda M, Benedict K, Jackson BR. Invasive Aspergillosis After Influenza and Other Viral Respiratory Infections Among Intensive Care Unit Patients in a Commercially Insured Population in the United States, 2013-2018. Open Forum Infect Dis. 2021 Feb 26
Welsh RM, Misas E, Forsberg K, Lyman M, Chow NA. Candida auris Whole-Genome Sequence Benchmark Dataset for Phylogenomic Pipelines. J Fungi (Basel). 2021 Mar 16;7(3):214.
Zhang SX, Babady NE, Hanson KE, Herrington AT, Larkin PMK, Leal Jr. SM, et al. Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC). J Clin Microbiol. 2021 Jan 27

Almaghrabi R, Albalawi R, Mutabagani M, Atienza E, Aljumaah S, Gade L, et al. Molecular characterization and clinical outcomes of Candida auris infection single-center experience in Saudi Arabia. Mycoses. 2020 Feb 18
Alvarado M, Bartolomé Álvarez J, Lockhart SR, Valentín E, Ruiz-Gaitán AC, Eraso E, et al. Identification of Candida auris and related species by multiplex PCR based on unique GPI protein-encoding genes. Mycoses. 2020 Oct 31
Ashraf N, Kubat RC, Adenis AA, Denning DW, Wright L, McCotter O, et al. Re-drawing the maps for endemic mycoses. Mycopathologia. 2020 Feb 10
Beer KD, Jackson BR, Chiller T, Verweij PE, Van de Veerdonk FL, Wauters J. Does pulmonary aspergillosis complicate COVID-19? Crit Care Exp. 2020 Sep 18
Benedict K, Jackson BR. Sporotrichosis cases in commercial insurance data, United States, 2012–2018. Emerg Infect Dis. 2020 Oct 14
Benedict K, Kobayashi M, Shikha Garg S, Chiller T, Jackson BR. Symptoms in blastomycosis, coccidioidomycosis, and histoplasmosis versus other respiratory illnesses in commercially insured adult outpatients, United States, 2016–2017. Clin Infect Dis. 2020 Oct 16
Benedict K, McCotter OZ, Jackson BR. Coccidioidomycosis skin testing in a commercially insured population, United States, 2014-2017. Emerg Infect Dis. 2020 Mar
Benedict K, McCracken S, Signs K, Ireland M, Amburgey V, Serrano JA, et al. Enhanced surveillance for histoplasmosis — nine states, 2018–2019. Open Forum Infect Dis. 2020 Aug 17
Benedict K, Molinari NA, Jackson BR. Public awareness of invasive fungal diseases — United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Sept 24
Benedict K, Shantha JG, Yeh S, Beer KD, Jackson BR. Presumed ocular histoplasmosis syndrome in a commercially insured population, United States. PLoS One. 2020 Mar 13
Benedict K, Thompson GR, Jackson BR. Cannabis use and fungal infections in a commercially insured population, United States, 2016. Emerg Infect Dis. 2020 June
Berkow EL, Lockhart SL, Ostrosky-Zeicher L. Antifungal susceptibility testing: current approaches. Clin Microbiol Rev. 2020 Apr 29
Bowers JR, Monroy-Nieto J, Gade L, Travis J, Refojo N, Abrantes R, et al. Rhizopus microsporus infections associated with surgical procedures, Argentina, 2006-2014. Emerg Infect Dis. 2020 May
Caceres DH, Chiler T, Lindsley MD. Immunodiagnostic assays for the investigation of fungal outbreaks. Mycopathologia. 2020 May 26
Caceres DH, Fernandez NB, Lockhart SR. Innovative approaches for Histoplasma detection. Curr Fungal Infect Rep. 2020 June 6
Caceres DH, Mohd Tap R, Alastruey-Izquierdo A, Ferry H. Detection and control of fungal outbreaks. Mycopathologia. 2020 Oct 10
Caceres DH, Rivera SM, Armstrong PA, Escandon P, Chow NA, Ovalle MV, et al. Case-case comparison of Candida auris versus other Candida species bloodstream infections: results of an outbreak investigation in Colombia. Mycopathologia. 2020 Aug 29
Chow NA, Chinn R, Pong A, Schultz K, Kim J, Gade L, et al. Use of whole-genome sequencing to detect an outbreak of Malassezia pachydermatis infection and colonization in a neonatal intensive care unit-California, 2015-2016. Infect Control Hosp Epidemiol. 2020 May 6
Chow NA, Muñoz JF, Gade L , Berkow E, Li X, Welsh RM, et al. Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses. BioRxiv. 2020 Jan 7
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020 Sept 15
Fernandez NB, Caceres DH, Beer K, Irrazabal C, Delgado G, Farias L, et al. Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina. Med Mycol Case Rep. 2020 Jul 5
Gade L Munos JF, Sheth M, Wagner D, Caceres DH, Berkow EL, et al. Understanding the emergence of multidrug-resistant Candida: Using whole-genome sequencing to describe the population structure of Candida haemulonii species complex. Frontiers. 2020 May 7
Garcias-Jeldes HF, Mitchel R, McGeer A, Rudnick W, Amaratunga K, Vallabhaneni S, et al. Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018. Antimicrob Resist Infect Cont. 2020 June 10
Georgacopoulos O, Nunnally NS, Le N, Lysen C, Welsh RM, Kordalewska M, et al. Performance evaluation of culture-independent SYBR Green Candida auris qPCR diagnostics on anterior nares surveillance swabs. J Clin Microbiol. 2020 Jun 24
Ghannoum M, Arendrup MC, Chaturvedi VP, Lockhart SR, McCormick TS, et al. Ibrexafungerp: a novel oral triterpenoid antifungal in development for the treatment of Candida auris infections. Antibiotics. 2020 Aug 25
Gold JR, Jackson BR, Benedict K. Possible diagnostic delays and missed prevention opportunities in Pneumocystis pneumonia patients without HIV: analysis of commercial insurance claims data — United States, 2011–2015. Open Forum Infect Dis. 2020 Jun 29
Greene G, Lawrence D, Jordan A, Chiller T, Jarvis JN. Cryptococcal meningitis: a review of cryptococcal antigen screening programs in Africa. Expert Rev Anti Infect Ther. 2020 Jun 22
Haumba SM, Toda M, Jeffries R, Ehrenkranz P, Pasipamire M, Ao T, et al. Prevalence of cryptococcal antigen (CrAg) among HIV-positive patients in Eswatini, 2014–2015. Afric J Lab Med. 2020 Jul 29
Indira B, Caceres DH, Wilfrido Coronell R, Salcedo S, Mora L, Marin A, et al. Bloodstream infections with Candida auris among children in Colombia: clinical characteristics and outcomes of 34 cases. J Ped Infect Dis Soc. 2020 May 6
Lockhart SR, Beer K, Toda M. Azole-resistant Aspergillus fumigatus: what you need to know. Clin Microb News. 2020 Jan
Magobo RE, Lockhart SR, Govender NP, TRAC-South Africa group. Fluconazole-resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa. Mycoses. 2020 Mar 2
Malani AN, Kauffman CA, Latham R, Peglow S, Ledtke CS, Kerkering TM, et al. Long-term outcomes of patients with fungal infections associated with contaminated methylprednisolone injections. Open Forum Infect Dis. 2020 May 9
McPherson TD, Walblay KA, Roop E, Soglin D, Valley A, Logan LK, et al. Notes from the field: Candida auris and carbapenemase-producing organism prevalence in a pediatric hospital providing long-term transitional care – Chicago, Illinois, 2019. MMWR Morb Mortal Wkly Rep. 2020 Aug 28
Messina F, Marin E, Caceres DH, Romero M, Depardo R, Priarone MM, et al. Coronavirus disease 2019 (COVID‐19) in a patient with disseminated histoplasmosis and HIV— a case report from Argentina and literature review. J Fungi. 2020 Nov 10
Misas E, Chow NA, Gómez OM, Muñoz JF, McEwen JG, Litvintseva AP, et al. Mitochondrial genome sequences of the emerging fungal pathogen Candida auris. Front Microbiol. 2020 Oct 27
Modlin CE, Collins LF, Burdb EM, Lockhart SR, Lyon M. Acrophialophora levis brain abscess in a kidney transplant patient: a case report and review of the literature. 2020 Mar 10
Oladele RO, Jordan A, Akande P, Akanmu SA, Akase IE, Aliyu S, et al. Tackling cryptococcal meningitis in Nigeria, one-step at a time; the impact of training. PLoS One. 2020 Jul 6
Oltean HN , Springer M, Bowers JR, Barnes R, Reid G, Valentine M, et al. Suspected locally acquired coccidioidomycosis in human, Spokane, Washington, USA. Emerg Infect Dis. 2020 Jan 8
Ostrowsky B, Greenko J, Adams E, Quinn M, O’Brien B, Chaturvedi V, et al. Candida auris isolates resistant to three classes of antifungal medications — New York, 2019. MMWR Morb Mortal Wkly Rep. 2020 Jan 10
Pacilli M, Kerins JL, Clegg WJ, Walblay KA, Adil H, Kemble SK, et al. Regional emergence of Candida auris in Chicago and lessons learned from intensive follow-up at one ventilator-capable skilled nursing facility. Clin Infect Dis. 2020 Apr 14
Pan American Health Organization, World Health Organization. Guidelines for diagnosing and managing disseminated histoplasmosis among people living with HIV. IRIS PAHO. 2020 Jun 18
Patel JB, Thomson RB, Alby K, Babady E, Culbreath K, Galas MF, et al. Expert opinion on verification of antimicrobial susceptibility tests. J Clin Microbiol. 2020 Jun 3
Penumarthi LR, La Hoz RM, Wolfe CR, Jackson BR, Mehta AK, Malinis M, et al. Cryptococcus transmission through solid organ transplantation in the United States: a report from the Ad Hoc Disease Transmission Advisory Committee. Am J Transplant. 2020 Dec 8
Rodriguez Tudela JL, Cole DC, Ravasi G, Bruisma N, Chiller TC, Ford N, et al. Integration of fungal diseases into health systems in Latin America. Lancet Infect Dis. 2020 Jun 30
Rossow JA, Gharpure R, Brennan J, Relan P, Williams SR, Vallabhaneni S, et al. Injection drug use-associated candidemia: incidence, clinical features, and outcomes, East Tennessee, 2014–2018. 2020 Sept 2
Rossow JA, Ostrowsky B, Adams E, Greenko J, McDonald R, Vallabhaneni S, et al. Factors associated with Candida auris colonization and transmission in skilled nursing facilities with ventilator units, New York, 2016–2018. Clin Infect Dis. 2020 Sept 28
Rossow JA, Queiroz-Telles F, Caceres DH, Beer KD, Jackson BR, Guillermo Pereira J, et al. A One Health approach to combatting Sporothrix brasiliensis: narrative review of an emerging zoonotic fungal pathogen in South America. J Fungi. 2020 Oct 26
Rybak JM, Munoz JF, Barker KS, Parker JE, Esquivel BD, Berkow EL, et al. Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in Candida auris. mBio. 2020 May 12
Sexton JD, Welsh RM, Bentz LM, Forsberg K, Jackson B, Berkow EL, et al. Evaluation of nine surface disinfectants against Candida auris using a quantitative disk carrier method: EPA SOP-MB-35. Infect Control Hosp Epidemiol. 2020 Jun 30
Shroufi A, Chiller T, Jordan A, Denning DW, Harrison TS, Govender NP, et al. Ending deaths from HIV-related cryptococcal meningitis by 2030. Lancet Infect Dis. 2020 Dec 1
Temfack E, Rim JJB, Spijker R, Loyse A, Chiller T, Pappas PG, et al. Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with HIV: systematic review and meta-analysis of diagnostic test accuracy studies. Clin Infect Dis. 2020 Aug 23
Tenforde MW, Muthoga C, Callaghan A, Ponatshego P, Ngidi J, Mine M, et al. Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana. Wellcome Open Res. 2020 Mar 13
Tenforde MW, Milton T, Rulaganyang I, Muthoga C, Tawe L, Chiller T, et al. Outcomes of reflex cryptococcal antigen (CrAg) screening in HIV-positive patients with CD4 counts of 100-200 cells/µL in Botswana. Clin Infect Dis. 2020 Jun 30
Theodoropoulos NM, Bolstorff B, Bozorgzadeh A, Brandeburg C, Cumming M, Daly JS, et al. Candida auris outbreak involving liver transplant recipients in a surgical intensive care unit. Am J Transplant. 2020 Jun 12
Thevissen K, Jacobs C, Holtappels M, Toda M, Verweij P, Wauters J. International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe. Crit Care. 2020 Mar 11
Toda M, Beekmann SE, Polgreen PM, Chiller TM, Jackson BR, Beer KD. Knowledge of infectious disease specialists regarding aspergillosis complicating influenza, United States. Emerg Infect Dis. 2020 Apr
Traxler RM, Beer KD, Blaney DD, van de Sande WWJ, Fahal AH, Asiedu KB, et al. Development of the Global Mycetoma Working Group. Trans R Soc Trop Med Hyg. 2020 Dec 15
Tsay SV, Mu Y, Williams S, Epson E, Nadle J, Bamberg WM, et al. Burden of candidemia in the United States, 2017. Clin Infect Dis. 2020 Feb 28
Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 Jun 22
Yorlady V, Cáceres DH, de Bedout C, Cano LE, Restrepo Á. Frequency of invasive fungal disease in adults: experience of a specialized laboratory in Medellín, Colombia (2009-2015). J Fungi. 2020 Mar 20

Ahmad A, Spencer JE, Lockhart SR, Singleton S, Petway DJ, Bagarozzi DA Jr, Herzegh OT. A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris. Mycoses. 2019 Feb 23.
Ambaraghassi G, Dufresne PJ, Dufresne SF, Vallières É, Muñoz JF, Cuomo CA, Berkow EL, et al. Identification of Candida auris using the updated 8.01 VITEK®2 yeast identification system: a multi-laboratory evaluation study. 2019 Aug 14.
Armstrong PA, Rivera SM, Escandon P, Caceres DH, Chow N, Stuckey MJ, Díaz J, et al. Hospital-associated multicenter outbreak of emerging fungus Candida auris, Colombia, 2016. Emerg Infect Dis. 2019 Jul.
Barker BM, Litvintseva AP, Riquelme M, Vargas-Gastélum Coccidioides ecology and genomics. Medical Mycology. 2019 Feb 1.
Barter DM, Johnston HL, Williams SR, Tsay SV, Vallabhaneni S, Bamberg WM. Candida bloodstream infections among persons who inject drugs – Denver metropolitan area, Colorado, 2017-2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29.
Benedict K, Beer KD, Jackson BR. Histoplasmosis-related healthcare use, diagnosis, and treatment in a commercially insured population, United States. Clinical Infectious Diseases. 2019 April 30.
Benedict K, McCotter OZ, Brady S, Komatsu K, Sondermeyer-Cooksey GL, Nguyen A, Jain S, et al. Surveillance for coccidioidomycosis — United States, 2011–2017. MMWR. 2019 Sept 20.
Bongomin, F, et al. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations. Eur J Clin Microbial Infect Dis. 2019 Jun 7.
Brooks RB, Walters M, Forsberg K, Vaeth E, Woodworth K, Vallabhaneni S. Candida auris in a U.S. patient with carbapenemase-producing organisms and recent hospitalization in Kenya. MMWR Morb Mortal Wkly Rep. 2019 Aug 2.
Caceres DH, Adenis A, Braga de Souza JV, Gomez BL, Santana Cruz K, Pasqualotto AC, Ravasi G, et al. The Manaus Declaration: current situation of histoplasmosis in the Americas, report of the II regional meeting of the International Histoplasmosis Advocacy Group. Curr Fungal Infect Rep. 2019 Nov 27.
Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, Chiller T. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi. 2019 Nov 28.
Caceres DH, Gómez BL, Tobón AM, Chiller TM, Lindsley MD. Evaluation of a Histoplasma antigen Lateral Flow Assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS. Mycoses. 2019 Oct 18.
Caceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of progressive disseminated histoplasmosis in advanced HIV: a meta-analysis of assay analytical performance. J Fungi. 2019 Aug 18.
Caceres DH, Valdes A. Histoplasmosis and tuberculosis co-occurrence in people with advanced HIV. J Fungi. 2019 Aug 5.
Chi GC, Benedict K, Beer KD, Jackson BR, McCotter O, Xie F, Lawrence JM, et al. Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis – Southern California, 2011. Med Mycol. 2019 Jul 9.
Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF. Potential fifth clade of Candida auris, Iran, 2018. Emerg Infect Dis. 2019 July 16.
Chow, NA et al. Hurricane-associated mold exposures among patients at risk for invasive mold infections after Hurricane Harvey – Houston, Texas, 2017. MMWR Morb Mortal Wkly Rep. 2019 May 31.
Cogliati M, Desnos-Ollivier M, McCormick-Smith I, Rickerts V, Ferreira-Paim K, Wieland M, Boekhout T, et al. Genotypes and population genetics of Cryptococcus neoformans and Cryptococcus gatti species complexes in Europe and the Mediterranean area. Fungal Genetics and Biology. 2019 April 3.
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2019 Dec 5.
Donovan FM, Wightman P, Zong Y, Gabe L, Majeed A, Ynosencio T, Bedrick EJ, et al. Delays in coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA. Emerg Infect Dis. 2019 Sept.
Gade L, McCotter OZ, Bowers JR, Waddell V, Brady S, Carvajal JA, Sunenshine R, et al. The detection of Coccidioides from ambient air in Phoenix, Arizona: Evidence of uneven distribution and seasonality. Medical Mycology. 2019 Sept 10.
Govender NP, Meintjes G, Mangena P, Nel J, Potgieter S, Reddy D, et al. Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update. South Afr J HIV Med. 2019 Nov 8.
Hartnett KP, Jackson BR, Perkins KM, Glowicz J, Kerins JL, Black SR, Lockhart SR, Christensen BE, Beer KD. A guide to investigating suspected outbreaks of mucormycosis in healthcare. J Fungi. 2019 Jul 24.
Hata DJ, Humphries R, Lockhart SR, College of American Pathologists Microbiology Committee. Candida auris: an emerging yeast pathogen posing distinct challenges for laboratory diagnostics, treatment, and infection prevention. Arch Pathol Lab Med. 2019 Jun 6.
Hay R, Denning DW, Bonifaz A, Queiroz-Telles F, Beer K, Bustamante B, Chakrabarti A, et al. The diagnosis of fungal Neglected Tropical Diseases (Fungal NTDs) and the role of investigation and laboratory tests: an expert consensus report. Trop Med Infect Dis. 2019 Sep 24.
Hurst S, Lysen C, Cooksey G, Vugia DJ, Litvintseva AP, Lockhart SR. Molecular typing of clinical and environmental isolates of Cryptococcus gattii species complex from Southern California, United States. 2019 Aug 3.
Jackson BR, Chow N, Forsberg K, Litvintseva AP, Lockhart SR, Welsh R, Vallabhaneni S, et al. On the origins of a species: what might explain the rise of Candida auris? J Fungi. 2019 Jul 6.
Lockhart SR. Candida auris and multidrug resistance: defining the new normal. Fungal Genet Biol. 2019 June 20.
Lockhart SR, Gary JM. Is this zebra really a zebra? the challenge of diagnosing rare fungal infections in veterinary pathology. Vet Pathol. 2019 Jul.
McCotter OZ, Benedict K, Engelthaler DM, Komatsu K, Lucas KD, Mohle-Boetani JC, et al. Update on the epidemiology of coccidioidomycosis in the United States. Med Mycol. 2019 Feb 1;57(Supplement_1):S30-S40.
McCotter OZ, Kennedy J, McCollum J, Bartholomew M, Iralu J, Jackson BR, Haberling D, et al. Coccidioidomycosis among American Indians and Alaska Natives, 2001–2014. Open Forum infectious Diseases. 2019 March 11.
Nunnally NS, Etienne KA, Angulo D, Lockhart SR, Berkow EL. In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations. Antimicrob Agents Chemother. 2019 Sep 3.
Oltean HN, Etienne KA, Roe CC, Gade L, McCotter OZ, Engelthaler DM, Litvintseva AP. Utility of whole-genome sequencing to ascertain locally acquired cases of coccidioidomycosis, Washington, USA. Emerg Infect Dis. 2019 Mar
Rajasingham R, Meya DB, Greene GS, Jordan A, Nakawuka M, Chiller TM, et al. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis. PloS one. 2019;14(1):e0210105.
Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, Lockhart SR, et al. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection. PLoS Pathog. 2019 Aug 5.
Teixeira MM, Alvarado P, Roe CC, Thompson GR 3rd, Patané JSL, Sahl JW, Keim P, et al. Population structure and genetic diversity among isolates of Coccidioides posadasii in Venezuela and surrounding regions. MBio. 2019 Nov 26.
Tenforde MW, Muthoga C, Callaghan A, Ponetshego P, Ngidi J, Mine M, et al. Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana. Wellcome Open Res. 2019 Sep 25.
Toda M, Gonzalez FJ, Fonseca-Ford M, et al. Notes from the field: multistate coccidioidomycosis outbreak in U.S. residents returning from community service Trips to Baja California, Mexico — July–August 2018. MMWR Morb Mortal Wkly Rep 2019 Apr 12.
Toda M, Williams SR, Berkow EL, Farley MM, Harrison LH, Bonner L, Marceaux KM, et al. Population-based active surveillance for culture-confirmed candidemia — four sites, United States, 2012–2016. MMWR. 2019 Sept 27.
Vallabhaneni S, Jackson BR, Chiller TM. Candida auris: an emerging antimicrobial resistance threat. Ann Intern Med. 2019 Jul 30.
Verweij PE, Brüggemann RJM, Wauters J, Rijnders BJA, Chiller T, van de Veerdonk F. Influenza coinfection: be(a)ware of invasive aspergillosis. Clin Infect Dis. 2019 May 11.
Vogelzang EH, Weersink AJL, van Mansfeld R, Chow NA, Meis JF, van Dijk K. The first two cases of Candida auris in the Netherlands. J Fungi. 2019 Sep 30.
Welsh RM, Sexton DJ, Forsberg K, Vallabhaneni S, Litvintseva A. Insights into the unique nature of the East Asian clade of the emerging pathogenic yeast, Candida auris. J Clin Microbiol. 2019 Feb 13.
Yu CH, Chen Y, Desjardins CA, Tenor JL, Toffaletti DL, Giamberardino C, et al. Landscape of gene expression variation of natural isolates of Cryptococcus neoformans in response to biologically relevant stresses. Microb Genom. 2019 Dec 20.
Zhang AY, Shrum S, Williams S, Petnic S, Nadle J, Johnston H, Barter D, et al. The changing epidemiology of candidemia in the United States: injection drug use as an increasingly common risk factor – active surveillance in selected sites, United States, 2014–17. Clin Infect Dis. 2019 Nov 2.

Adams E, Quinn M, Tsay S, Poirot E, Chaturvedi S, et al.Candida auris in Healthcare Facilities, New York, USA, 2013-2017. Emerg Infect Dis. 2018 Oct;24(10):1816-1824.
Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, Chiller T, Nacher M. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018 Aug 23.
Armstrong PA, Jackson BR, Haselow D, Fields V, Ireland M, Austin C, et al. Multistate Epidemiology of Histoplasmosis, United States, 2011-2014. Emerging infectious diseases. 2018 Mar;24(3):425-31.
Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, et al. Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection (OTIP) Study: a Multi-Year, Multi-Center Prospective Cohort Study. Transpl Infect Dis. 2018 Mar 7.
Beer KD, Blaney DD, Kadzik M, Kingsley BA, Sheih W, Bower W, et al. A Call to Action for Mycetoma. Current Fungal Infection Reports. 2018 Jul 18.
Beer, KD, Farnon, EC, Jain, S, Jamerson, C, Lineberger, S, Miller, J, Berkow, EL, Lockhart, SR, Chiller, T, Jackson, BR. Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure — Three States, 2010–2017. MMWR Morb Mortal Wkly Rep. 2018 Sept 28
Benedict K, Ireland M, Weinberg MP, Gruninger RJ, Weigand J, Chen L, et al. Enhanced Surveillance for Coccidioidomycosis, 14 US States, 2016. Emerg Infect Dis. 2018 Jul;24(8):1444-1452.
Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2018 Sep 10.
Benedict K, Roy M, Kabbani S, Anderson EJ, Farley MM, Harb S, et al. Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015. J Pediatric Infect Dis Soc. 2018 Mar 7.
Berkow EL, Lockhart SR. Activity of novel antifungal compound APX001A against a large collection of Candida auris. J Antimicrob Chemother. 2018 Aug 1. doi: 10.1093/jac/dky302.
Berkow EL, Nunnally NS, Bandea A, Kuykendall R, Beer K, Lockhart SR. Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017. Antimicrobial agents and chemotherapy. 2018 Feb 20.
Bentz ML, Sexton DJ, Welsh RM, Litvintseva AP. Phenotypic switching in newly emerged multidrug-resistant pathogen Candida auris. Med Mycol. 2018 Oct 16.
Cáceres DH, Samayoa BE, Medina NG, Tobón AM, Guzmán BJ, Mercado D, et al. Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV/AIDS in two Latin American countries. J Clin Microbiol. 2018 Mar 21.
Caceres DH, Tobon AM, Restrepo A, Chiller T, Gomez BL. The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia. Med Mycol Case Rep. 2018 Mar;19:41-4.
Chow NA, Gade L, Batra D, Rowe LA, Juieng P, Loparev VN, Litvintseva AP. Genome Sequence of the Amphotericin B-Resistant Candida duobushaemulonii Strain B09383. Genome Announc. 2018 Mar 29;6(13).
Chow NA, Gade L, Batra D, Rowe LA, Juieng P, Ben-Ami R, Loparev VN, Litvintseva AP. Genome Sequence of a Multidrug-Resistant Candida haemulonii Isolate from a Patient with Chronic Leg Ulcers in Israel. Genome Announc. 2018 Apr 12;6(15). pii: e00176-18.
Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. The Lancet infectious diseases. 2018 Oct 4.
Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, et al. Epidemiology and Outcomes of Clostridium difficile Infection in Allogeneic Hematopoietic Cell and Lung Transplant Recipients. Transplant infectious disease. 2018 Feb 10.
Escandon P, Caceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, et al. Notes from the Field: Surveillance for Candida auris – Colombia, September 2016-May 2017. MMWR. 2018 Apr 20;67(15):459-60.
Escandon P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly-related, country-wide colonization with regional patterns in Amphotericin B resistance. Clinical infectious diseases. 2018 May 16.
Ford N, Shubber Z, Jarvis JN, Chiller T, Greene G, Migone C, et al. CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis. Clinical infectious diseases. 2018 Mar 4;66(suppl_2):S152-S9.
Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2018 Jul 31. doi: 10.1093/mmy/myy054.
Freedman M, Jackson BR, McCotter O, Benedict K. Coccidioidomycosis Outbreaks, United States and Worldwide, 1940-2015. Emerging infectious diseases. 2018 Mar;24(3):417-23.
Goodman AL, Lockhart SR, Lysen CB, Westblade LF, Burnham CD, Burd EM. Two cases of fungal keratitis caused by Metarhizium anisopliae. Med Mycol Case Rep. 2018 Mar 6;21:8-11.
Hashemi MM, Rovig J, Holden BS, Taylor MF, Weber S, Wilson J, et al. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms. J Antimicrob Chemother. 2018 Apr 4.
Iverson WO, Karanth S, Wilcox A, Pham CD, Lockhart SR, Nicholson SM. Talaromycosis (Penicilliosis) in a Cynomolgus Macaque. Vet Pathol. 2018 Jan 1:300985818758468.
Khan S, Saubolle MA, Oubsuntia T, Heidari A, Barbian K, Goodin K, et al. Interlaboratory agreement of coccidioidomycosis enzyme immunoassay from two different manufacturers. Med Mycol. 2018 Jul 31. doi: 10.1093/mmy/myy059.
Lamoth F, Lockhart SR, Berkow EL, Calandra T. Changes in the epidemiological landscape of invasive candidiasis. The Journal of antimicrobial chemotherapy. 2018 Jan 1;73(suppl_1):i4-i13.
Lockhart SR, Roe CC, Engelthaler DM. Timing the Origin of Cryptococcus gattii sensu stricto, Southeastern United States. Emerg Infect Dis. 2018 Nov;24(11):2095-2097.
Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, et al. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis. 2018 Oct 18. pii: S1473-3099(18)30493-6.
McCarty TP, Lockhart SR, Moser SA, Whiddon J, Zurko J, Pham CD, et al. Echinocandin resistance among Candida isolates at an academic medical centre 2005-15: analysis of trends and outcomes. The Journal of antimicrobial chemotherapy. 2018 Feb 28.
McDonald R, Duford E, Jackson BR, Tobin EH, Newman A, Benedict K, et al. Notes from the Field: Blastomycosis Cases Occurring Outside of Regions with Known Endemicity — New York, 2007–2017 MMWR Morb Mortal Wkly Rep. 2018 Sept 28.
Muñoz JF, Gade L, Chow NA, Loparev VN, Juieng P, Berkow EL, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nature Communications. 2018 2018/12/17;9(1):5346.
Ramos R, Caceres DH, Perez M, Garcia N, Castillo W, Santiago E, et al. Emerging multidrug-resistant Candida duobushaemulonii infections in Panama hospitals: importance of laboratory surveillance and accurate identification. Journal of clinical microbiology. 2018 Apr 25.
Reich P, Shute T, Lysen C, Lockhart SR, Kelly Keating M, Custer P, et al. Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole. J Pediatric Infect Dis Soc. 2018 Mar 7.
Reichert Lima F, Lyra L, Pontes L, Moretti ML, Pham CD, Lockhart SR, et al. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B resistant isolates. Mycoses. 2018 Feb 22.
Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE, et al. Triazole resistance surveillance in Aspergillus fumigatus. Medical mycology. 2018 Apr 1;56(suppl_1):83-92.
Roe CC, Bowers J, Oltean H, DeBess E, Dufresne PJ, McBurney S, et al. Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest. mSphere. 2018 Jan-Feb;3(1).
Sexton DJ, Bentz ML, Welsh RM, Litvintseva AP. Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples. Mycoses. 2018 Jun 25.
Sexton DJ, Kordalewska M, Bentz ML, Welsh RM, Perlin DS, Litvintseva AP. Direct detection of emergent fungal pathogen Candida auris in clinical skin swabs by SYBR Green qPCR assay. J Clin Microbiol. 2018 Sep 19.
Tartof SY, Benedict K, Xie F, Rieg GK, Yu KC, Contreras R, et al. Testing for Coccidioidomycosis among Community-Acquired Pneumonia Patients, Southern California, USA. Emerg Infect Dis. 2018 Apr;24(4):779-781.
Tsay S, Williams SR, Benedict K, Beldavs Z, Farley M, Harrison L, et al. A Tale of Two Healthcare-Associated Infections: Clostridium difficile Coinfection Among Patients with Candidemia. Clin Infect Dis. 2018 Jul 27. doi: 10.1093/cid/ciy607.
Vallabhaneni S, Baggs J, Tsay S, Srinivasan AR, Jernigan JA, Jackson BR. Trends in antifungal use in US hospitals, 2006-12. The Journal of antimicrobial chemotherapy. 2018 Oct 1;73(10):2867-75.
Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d’Enfert C, et al. Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. Microbial cell (Graz, Austria). 2018 Jun 14;5(7):300-26.
Vasquez, A, Zavasky D, Chow NA, Gade L, Zlatanic E, Elkind S, et al al. Management of an outbreak of Exophiala dermatitidis bloodstream infections in an outpatient oncology clinic. Clinical Infectious Diseases, 66:959-962.
Vu K, Thompson GR 3rd, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, et al. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway. Med Mycol. 2018 Mar 15.
Walker TA, Lockhart SR, Beekmann SE, Polgreen PM, Santibanez S, Mody RK, et al. Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States. Emerging infectious diseases. 2018 Jan;24(1).
Wiederhold NP, Lockhart SR, Najvar LK, Berkow EL, Jaramillo R, Olivo M, et al. The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris. Antimicrobial agents and chemotherapy. 2018 Dec 10.
Wheeler C, Lucas KD, Derado G, McCotter O, Tharratt RS, Mohle-Boetani JC. Risk Stratification With Coccidioidal Skin Test to Prevent Valley Fever Among Inmates, California, 2015. J Corr Health Care. 2018 Aug 13.

Araúz AB, Caceres DH, Santiago E, Armstrong P, Arosemena S, Ramos C, et al. Isolation of Candida auris from nine patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses. 2017 Sep 25.
Armstrong PA, Beard JD, Bonilla L, Arboleda N, Lindsley MD, Chae S, et al. Outbreak of Severe Histoplasmosis Among Tunnel Workers – Dominican Republic, 2015. Clinical infectious diseases. 2017 Dec 2.
Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. 2017 Jul 31.
Berkow EL, Angulo D, Lockhart SR. In Vitro activity of a novel glucan synthase inhibitor, SCY-078, against clinical isolates of Candida auris. Antimicrob Agents Chemother. 2017 May 8.
Berkow EL, Lockhart SR. Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris. Diagnostic microbiology and infectious disease. 2017 Nov 7.
Berkow EL, Lockhart SR. Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist. 2017 Jul 31;10:237-245.
Caceres DH, Zuluaga A, Tabares AM, Chiller T, Gonzalez A, Gomez BL. Evaluation of a Cryptococcal antigen Lateral Flow Assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia. Rev Inst Med Trop Sao Paulo. 2017 Dec 21;59:e76.
Chen Y, Farrer RA, Giamberardino C, Sakthikumar S, Jones A, Yang T, et al. Microevolution of Serial Clinical Isolates of Cryptococcus neoformans grubii and C. gattii. MBio. 2017 Mar; 8(2).
Chow NA, Lindsley MD, McCotter OZ, Kangiser D, Wohrle RD, Clifford WR, et al. Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species. PLoS One. 2017 Apr 5;12(4):e0175081.
Cooksey GS, Nguyen A, Knutson K, Tabnak F, Benedict K, McCotter O, et al. Notes from the Field: Increase in Coccidioidomycosis – California, 2016. MMWR. 2017 Aug 11;66(31):833-4.
Coopersmith E, Bell J, Benedict K, Shriber J, McCotter O, Cosh M. Relating Coccidioidomycosis (Valley Fever) Incidence to Soil Moisture Conditions. GeoHealth. 2017 Mar.
Desjardins CA, Giamberardino C, Sykes SM, Yu CH, Tenor JL, Chen Y, et al. Population genomics and the evolution of virulence in the fungal pathogen Cryptococcus neoformans. Genome Res. 2017 Jun 13.
Dubberke ER, Reske KA, Olsen MA, Bommarito KM, Seiler S, Silveira FP, et al. Risk for Clostridium difficile Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period Transplant Direct. 2017 Mar 17;3(4):e145.
Ford N, Meintjes G, Vitoria M, Greene G, Chiller T. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017 Jan 5.
Greene G, Sriruttan C, Le T, Chiller T, Govender NP. Looking for fungi in all the right places: screening for cryptococcal disease and other AIDS-related mycoses among patients with advanced HIV disease. Curr Opin HIV AIDS. 2017 Mar;12(2):139-147.
Hurst SF, Berkow EL, Stevenson KL, Litvintseva AP, Lockhart SR. Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USA. J Antimicrob Chemother. 2017 Jun 1.
Kordalewska M, Zhao Y, Lockhart SR, Chowdhary A, Berrio I, Perlin DS. Rapid and accurate molecular identification of the emerging multidrug resistant pathogen Candida auris. J Clin Microbiol. 2017 May 24.
Lepak AJ, Zhao M, Berkow EL, Lockhart SR, Andes DR. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Antimicrob Agents Chemother. 2017 Jun 5.
Lockhart SR, Berkow EL, Chow N, Welsh RM. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin Microbiol Newsl. 2017 Jul 1;39(13):99-103.
Lockhart SR, Ghannoum MA, Alexander BD. Establishment and use of epidemiological cutoff values for molds and yeasts using the Clinical and Laboratory Standards Institute M57 standard. Journal of clinical microbiology. 2017 Feb 15.
Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T. Thinking beyond the common Candida species: Need for speciation of Candida due to the emergence of multidrug resistant Candida auris. J Clin Microbiol. 2017 Sep 13.
Lopez LF, Munoz CO, Caceres DH, Tobon AM, Loparev V, Clay O, et al. Standardization and validation of real time PCR assays for the diagnosis of histoplasmosis using three molecular targets in an animal model. PloS one. 2017;12(12):e0190311.
Magobo RE, Naicker SD, Wadula J, Nchabeleng M, Coovadia Y, Hoosen A, et al. Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory-based sentinel surveillance, South Africa, 2009-2010. Mycoses. 2017 Jan 19.
Molloy SF, Chiller T, Greene GS, Burry J, Govender N, Kanyama C, et al. Cryptococcal meningitis: A neglected NTD? PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575.
Montagna MT, De Donno A, Caggiano G, Serio F, De Giglio O, Bagordo F, et al. Molecular characterization of Cryptococcus neoformans and Cryptococcus gattii from environmental sources and genetic comparison with clinical isolates in Apulia, Italy. Environ Res. 2017 Oct 17;160:347-52.
Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC. Neglected endemic mycoses. Lancet Infect Dis. 2017 Jul 31.
Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017 May 5.
Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, et al.2017) A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases. Open Forum Infect Dis. 2017 Sep 26.
Rhodes J, Desjardins CA, Sykes SM, Beale MA, Vanhove M, Sakthikumar S, et al. Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level. Genetics. 2017 Jul 5.
Rick F, Niyibizi AA, Shroufi A, Onami K, Steele SJ, Kuleile M, et al. Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho. PLoS One. 2017 Sep 6;12(9):e0183656.
Samayoa B, Roy M, Cleveland AA, Medina N, Lau-Bonilla D, Scheel CM, et al. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017 Jul;97(1):42-48.
Schuster MG, Cleveland AA, Dubberke ER, Kauffman CA, Avery RK, Husain S, et al. Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study. Open Forum Infect Dis. 2017 Mar 22;4(2):ofx050.
Shriber J, Conlon KC, Benedict K, McCotter OZ, Bell JE. Assessment of Vulnerability to Coccidioidomycosis in Arizona and California. Int J Environ Res Public Health. 2017 Jun 23;14(7).
Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S. Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast. Clinical infectious diseases. 2017 Aug 17>.
Tsay S, Welsh R, Adams EH, Chow NA, Gade L, Berkow E, et al. Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017. MMWR. 2017 May 18.
Vallabhaneni S, Benedict K, Derado G, Mody RK. Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013. Open Forum Infect Dis. 2017 Jan 13;4(1):ofw268.
Vallabhaneni S, Sapiano M, Weiner LM, Lockhart SR, Magill S. Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011-2015. Open Forum Infect Dis. 2017 Fall;4(4):ofx175.
Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, et al. High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients. Clinical infectious diseases. 2017 Oct 05.
Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface. J Clin Microbiol. 2017 Jul 26.
Wiley Z, Woodworth MH, Jacob JT, Lockhart SR, Rouphael NG, Gullett JC, et al. Diagnostic Importance of Hyphae on Heart Valve Tissue in Histoplasma Endocarditis and Treatment With Isavuconazole. Open Forum Infect Dis. 2017 Fall;4(4):ofx241.

Benedict K, Chiller TM, Mody RK. Invasive Fungal Infections Acquired from Contaminated Food or Nutritional Supplements: A Review of the Literature. Foodborne Pathog Dis. 2016 Apr 13.
Benedict K, Derado G, Mody RK. Histoplasmosis-Associated Hospitalizations in the United States, 2001-2012. Open Forum Infect Dis 2016; 3:ofv219.
Benedict K, Mody RK. Epidemiology of Histoplasmosis Outbreaks, United States, 1938-2013. Emerg Infect Dis 2016 Mar; 22 (3).
Benedict K, Purfield AE, Mohle-Boetani J, Wheeler C, Park BJ. Awareness and Environmental Exposures Related to Coccidioidomycosis Among Inmates at Two California Prisons, 2013. J Correct Health Care. 2016 Apr;22(2):157-63.
Caceres DH, Tobón AM, Cleveland AA, Scheel CM, Berbesi DY, Ochoa J, et al. Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital. Am J Trop Med Hyg. 2016 Aug 1. pii: 15-0837.
Chibucos MC, Soliman S, Gebremariam T, Lee H, Daugherty S, Orvis J, et al. An integrated genomic and transcriptomic survey of mucormycosis-causing fungi. Nat Commun. 2016 Jul 22;7:12218.
Chow NA, Griffin DW, Barker BM, Loparev VN, Litvintseva AP. Molecular detection of airborne Coccidioides in Tucson, Arizona. Med Mycol. 2016 May 3. pii: myw022.
Cogliati M, D’Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, et al. Environmental distribution of Cryptococcus neoformans and Cryptococcus gattii around the Mediterranean basin. FEMS Yeast Res. 2016 May 5.
Engelthaler DM, Roe CC, Hepp CM, Teixeira M, Driebe EM, Schupp JM, et al. Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever. MBio. 2016 Apr 26;7(2).
Etienne KA, Roe CC, Smith RM, Vallabhaneni S, Duarte C, Escadon P, et al. Whole-Genome Sequencing to Determine Origin of Multinational Outbreak of Sarocladium kiliense Bloodstream Infections. Emerg Infect Dis 2016 Mar; 22 (3).
Ezeanolue EE, Nwizu C, Greene GS, Amusu O, Chukwuka C, Ndembi N, et al. Geographical Variation in Prevalence of Cryptococcal Antigenemia among HIV-infected Treatment-Naïve Patients in Nigeria: A multicenter cross-sectional study. J Acquir Immune Defic Syndr. 2016 May 3.
Firacative C, Roe CC, Malik R, Ferreira-Paim K, Escandón P, Sykes JE, et al. MLST and Whole-Genome-Based Population Analysis of Cryptococcus gattii VGIII Links Clinical, Veterinary and Environmental Strains, and Reveals Divergent Serotype Specific Sub-populations and Distant Ancestors. PLoS Negl Trop Dis. 2016 Aug 5.
Gade L, Hurst S, Balajee SA, Lockhart SR, Litvintseva AP. Detection of mucormycetes and other pathogenic fungi in formalin fixed paraffin embedded and fresh tissues using the extended region of 28S rDNA. Med Mycol. 2016 Sep 14.
Gold JA, Derado G, Mody RK, Benedict K. Sporotrichosis-Associated Hospitalizations, United States, 2000-2013. Emerg Infect Dis. 2016 Oct;22(10):1817-20.
Govender NP, Patel J, Magobo RE, Naicker S, Wadula J, Whitelaw A, et al. Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa. J Antimicrob Chemother. 2016 Apr 28. pii: dkw091.
Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D, et al. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun. 2016 Mar 29;7:11128.
Larson BA, Rockers PC, Bonawitz R, Sriruttan C, Glencross DK, Cassim N, et al. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016 Jul 8;11(7):e0158986.
Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug resistant Candida auris on three continents confirmed by whole genome sequencing and epidemiological analyses. Clin Infect Dis, 2016, Oct 20.
Lockhart SR, Fothergill AW, Iqbal N, Bolden CB, Grossman NT, Garvey EP, et al. The Investigational Fungal Cyp51 Inhibitor VT-1129 Demonstrates Potent In Vitro Activity against Cryptococcus neoformans and Cryptococcus gattii. Antimicrob Agents Chemother. 2016 Jan 19.
Lockhart SR, McCotter OZ, Chiller TM. Emerging Fungal Infections in the Pacific Northwest: The Unrecognized Burden and Geographic Range of Cryptococcus gattii and Coccidioides immitis. Microbiol Spectr. 2016; 4(3).
Lockhart SR, Roe CC, Engelthaler DM. Whole-Genome Analysis of Cryptococcus gattii, Southeastern United States. Emerg Infect Dis. 2016 Jun;22(6).
Novosad SA, Vasquez AM, Nambiar A, et al. Notes from the Field: Probable Mucormycosis Among Adult Solid Organ Transplant Recipients at an Acute Care Hospital — Pennsylvania, 2014–2015. MMWR 2016;65:481–482.
Souto AC, Bonfietti LX, Ferreira-Paim K, Trilles L, Martins M, Ribeiro-Alves M, et al. Population Genetic Analysis Reveals a High Genetic Diversity in the Brazilian Cryptococcus gattii VGII Population and Shifts the Global Origin from the Amazon Rainforest to the Semi-arid Desert in the Northeast of Brazil. PLoS neglected tropical diseases 2016; 10(8): e0004885.
Vallabhaneni S, Chiller TM. Fungal Infections and New Biologic Therapies. Curr Rheumatol Rep. 2016 May;18(5):29.
Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J, et al. Investigation of the first seven reported U.S. cases of Candida auris, a globally-emerging invasive fungus — United States, May 2013–August 2016. MMWR, 2016, Nov 4.
Vallabhaneni S, Longley N, Smith M, Smith R, Osler M, Kelly N, et al. Evaluation of a Public-sector, Provider-initiated Cryptococcal Antigen Screening and Treatment Program, Western Cape, South Africa. J Acquir Immune Defic Syndr. 2016 Feb 29.
Vasquez AM, Lake J, Ngai S, Halbrook M, Vallabhaneni S, Keckler MS, et al. Notes from the Field: Fungal Bloodstream Infections Associated with a Compounded Intravenous Medication at an Outpatient Oncology Clinic – New York City, 2016. MMWR. 2016 Nov 18;65(45):1274-1275.

Benedict K, Thompson GR 3rd, Deresinski S, Chiller T. Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerg Infect Dis. 2015 Nov;21(11):1935-41.
Chibucos MC, Etienne KA, Orvis J, Lee H, Daugherty S, Lockhart SR, Ibrahim AS, Bruno VM. The genome sequence of four isolates from the family Lichtheimiaceae. Pathog Dis. 2015 Apr 9. pii: ftv024.
Cleveland AA, Harrison LH, Farley MM, Hollick R, Stein B, Chiller TM, et al. Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008-2013: Results from Population-Based Surveillance. PloS one. 2015;10(3):e0120452.
Espinel-Ingroff A, Alvarez-Fernandez M, Canton E, Carver PL, Chen SC, Eschenauer G, et al. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrobial agents and chemotherapy. 2015 Nov;59(11):6725-32.
Forrest GN, Bhalla P, DeBess EE, Winthrop KL, Lockhart SR, Mohammadi J, et al. Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases. Transplant infectious disease. 2015 Feb 9.
Franco-Paredes C, Womack T, Bohlmeyer T, Sellers B, Hays A, Patel K, et al. Management of Cryptococcus gattii meningoencephalitis. The Lancet infectious diseases. 2015 Mar;15(3):348-55.
Fridkin SK, Cleveland AA, See I, Lynfield R. Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance. Emerg Infect Dis. 2015 Sep;21(9):1578-81.
Govender NP, M Roy, JF Mendes, TG Zulu, TM Chiller, and AS Karstaedt. Evaluation of screening and treatment of cryptococcal antigenemia among HIV-infected persons in Soweto, South Africa. HIV Medicine 2015; DOI 10.1111/hiv.12245
Greene G, S Vallabhaneni, JH Chung, T Chiller. Cryptococcal Antigen Screening and Treatment: The Current state of Global Screening Programs to Prevent Death from Cryptococcal Infection. Curr Fungal Infect Repts 2015; DOI 10.1007/s12281-015-0246-x.
Grossman NT, Pham CD, Cleveland AA, Lockhart SR. Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system. Antimicrobial agents and chemotherapy. 2015 Feb;59(2):1030-7.
Jabeen K, Kumar H, Farooqi J, Mehboob R, Brandt ME, Zafar A. Agreement of the direct antifungal susceptibility testing from positive blood culture bottles with conventional method for Candida species. J Clin Microbiol. 2015 Nov 25. pii: JCM.02432-15.
Kaplan JE, Vallabhaneni S, Smith RM, Chideya-Chihota S, Chehab J, Park B. Cryptococcal Antigen Screening and Early Antifungal Treatment to Prevent Cryptococcal Meningitis: A Review of the Literature. J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S331-S339.
Kuykendall RJ, Lockhart SR. Microbroth Dilution Susceptibility Testing of Candida species. Methods Mol Biol. 2016;1356:173-81.
Litvintseva AP, Brandt ME, Mody RK, Lockhart SR. Investigating Fungal Outbreaks in the 21st Century. PLoS Pathog. 2015 May 21. 11(5): e1004804
Lindsley MD, Ahn Y, McCotter O, Gade L, Hurst SF, Brandt ME, Park BJ, Litvintseva AP. Evaluation of the Specificity of Two Enzyme Immunoassays for Coccidioidomycosis using Sera from an Endemic and a Non-Endemic Region. Clin Vaccine Immunol. 2015 Aug 5.
Lockhart SR, Pham CD, Kuykendall RJ, Bolden CB, Cleveland AA. Candida lusitaniae MICs to the echinocandins are elevated but FKS-mediated resistance is rare. Diagn Microbiol Infect Dis. 2015 Aug 28.
McCarty TP, Baddley JW, Walsh TJ, Alexander BD, Kontoyiannis DP, Perl TM, et al. Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET). Med Mycol. 2015 Apr 23.
McCotter OZ, Smith RM, Westercamp M, Kerkering TM, Malani AN, Latham R, et al. Update on Multistate Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Injections, 2012-2014. MMWR. 2015 Oct 30;64(42):1200-1.
Pham CD, Purfield AE, Fader R, Pascoe N, Lockhart SR. Development of a Multi-Locus Sequence Typing System for Medically Relevant Bipolaris Species. J Clin Microbiol. 2015 Jul 22. pii: JCM.01546-15.
Ren P, Luo M, Lin S, Ghannoum MA, Isham N, Diekema DJ, et al. Multilaboratory testing of antifungal drug combinations against Candida species and Aspergillus fumigatus: utility of 100 percent inhibition as the endpoint. Antimicrobial agents and chemotherapy. 2015 Mar;59(3):1759-66.
Segel MJ, Rozenman J, Lindsley MD, Lachish T, Berkman N, Neuberger A, Schwartz E. Histoplasmosis in Israeli Travelers. Am J Trop Med Hyg. 2015 Apr 27.
Smith RM, Derado G, Wise M, Harris JR, Chiller TM, Meltzer MI, Park BJ. Estimated Deaths and Illnesses Averted During Fungal Meningitis Outbreak Associated with Contaminated Steroid Injections, United States, 2012–2013. Emerg Infect Dis. 2015; 21 (6).
Vallabhaneni S, Haselow D, Lloyd S, Lockhart S, Moulton-Meissner H, Lester L, et al. Cluster of Cryptococcus neoformans Infections in Intensive Care Unit, Arkansas, USA, 2013. Emerg Infect Dis. 2015; 21 (10).
Vallabhaneni S, Mody RK. Gastrointestinal Mucormycosis in Neonates: a Review. Curr Fungal Infect Repts 2015.
Vallabhaneni S, Walker TA, Lockhart SR, Ng D, Chiller T, Melchreit R, et al. Notes from the Field: Fatal Gastrointestinal Mucormycosis in a Premature Infant Associated with a Contaminated Dietary Supplement – Connecticut, 2014. MMWR. 2015 Feb 20;64(6):155-6.
Vallabhaneni S, Mody RK, Walker T, Chiller T. The Global Burden of Fungal Diseases. Infect Dis Clin North Am. 2015 Dec 28.
Vallabhaneni S, Purfield AE, Benedict K, Luvsansharav U, Lockhart SR, Pham CD, et al. Cardiothoracic surgical site phaeohyphomycosis caused by Bipolaris mould, multiple US states, 2008-2013: a clinical description. Med Mycol. 2015 Dec 24.
Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, et al. Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014. Open Forum Infect Dis. 2015 Dec;2(4):ofv163.
Vallabhaneni S, Almendares O, Farley MM, Reno J, Smith ZT, Stein B, et al. Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013. Epidemiol Infect. 2015 Nov 26:1-5.

Benedict K, Park BJ. Invasive Fungal Infections after Natural Disasters. Emerg Infect Dis. 2014;20(3).
Boehme AK, McGwin G, Andes DR, Lyon GM, Chiller T, Pappas PG, Baddley JW. Race and invasive fungal infection in solid organ transplant recipients. Ethn Dis.2014 Summer;24(3):382-5.
Caceres DH, Scheel CM, Tobón AM, Ahlquist Cleveland A, Restrepo A, Brandt ME, Chiller T, Gómez BL. Validation of a Histoplasma ELISA antigenuria test in Colombian patients with AIDS for diagnosis and follow-up during therapy. Clin Vaccine Immunol 2014 Jul 9.
DeBess E, Lockhart SR, Iqbal N, Cieslak PR. Isolation of Cryptococcus gattii from Oregon soil and tree bark, 2010-2011. BMC microbiology. 2014 Dec 21;14(1):323.
Doligalski CT, Benedict K, Cleveland AA, Park B, Derado G, Pappas PG, et al. Epidemiology of Invasive Mold Infections in Lung Transplant Recipients. Am J Transplant. 2014 Apr 11.
Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O’Connell H, et al. Mucormycosis Outbreak Associated with Hospital Linens. Ped Infect Dis J. 2014; 33(5):472-6.
Engelthaler DM, Hicks ND, Gillece JD, Row CC, Schupp JM, Driebe EM, et al. Cryptococcus gattii in North American Pacific Northwest: Whole-Population Genome Analysis Provides Insights into Species Evolution and Dispersal. MBio 2014 Jul 15; 5(4).
Etienne KA, MC Chibucos, Q Su, J Orvis, S Daugherty, S Ott, et al. Draft genome sequence of Mortierella alpina isolate CDC-B6842 [PDF – 2 pages]. Genome Announcements 2014;2:e01180-01181
Gade L, Grgurich DE, Kerkering TM, Brandt ME, Litvintseva AP. Utility of Real-Time PCR for detection of Exserohilum rostratum in body and tissue fluids during the multistate outbreak of fungal meningitis and other infections. J Clin Microbiol. 2014 Dec 17.
Kauffman CA, Freifeld AG, Andes DR, et al. Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET). Transpl Infect Dis. 2014 Mar 4.
Kelley EJ, Driebe EM, Etienne K, Brandt ME, Schupp JM, Gillece JD, et al. Real-time PCR assays for genotyping of Cryptococcus gattii in North America. BMC Microbiol. 2014 May 13;14(1):125. doi: 10.1186/1471-2180-14-125.
Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-B-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis 2014; 58 (5):622-630.
Litvintseva AP, Hurst S, Gade L, Frace MA, Hilsabeck R, Schupp JM, et al. Whole genome analysis of Exserohilum rostratum from the outbreak of fungal meningitis and other infections. J Clin Microbiol. 2014 Jun 20. pii: JCM.00936-14.
Litvintseva AP, Marsden-Haug N, Hurst S, Hill H, Gade L, Driebe EM, et al. Valley Fever: Finding new places for an old disease: Coccidioides immitis found in Washington State soil associated with recent human infection. Clin Infect Dis. 2014 Epub Aug 27.
Lockhart SR. Current epidemiology of Candida infection. Clin Microbiol Newsletter 2014; 36: 131-133
Marsden-Haug N, Hill H, Litvinseva A, Engelthaler DM, Driebe EM, Roe CC et al. Notes from the Field: Coccidioides immitis Identified in Soil Outside of Its Known Range — Washington, 2013. MMWR 2014; 63(20):450.
McKenney J, Smith RM, Chiller TM, Detels R, French A, Margolick J, Klausner JD. Prevalence and Correlates of Cryptococcal Antigen Positivity Among AIDS Patients — United States, 1986–2012.MMWR 2014; 63(27):585-587.
Mikosz CA, Smith RM, Kim M, et al. Fungal endophthalmitis associated with compounded products. Emerg Infect Dis. 2014;20(2):248-56.
Pham CD, Bolden CB, Kuykendall RJ, Lockhart SR. Development of a luminex-based multiplex assay for detection of mutations conferring resistance to echinocandins in Candida glabrata. J Clin Microbiol 2014;52(3):790-795.
Pham CD, Ahn S, Turner LA, Wohrle R, Lockhart SR. Development and validation of benomyl birdseed agar for the isolation of Cryptococcus neoformans and Cryptococcus gattii from environmental samples. Med Mycol. 2014 Apr 28.
Pham CD, Iqbal N, Bolden CB, Kuykendall RJ, Harrison LH, Farley MM, et al. The role of FKS mutations in C. glabrata: MIC values, echinocandin resistance and multidrug resistance. Antimicrob Agents Chemother. 2014 Jun 2. pii: AAC.03255-14.
Pham CD, Reiss E, Hagen F, Meis JF, Lockhart SR. Passive Surveillance for Azole-Resistant Aspergillus fumigatus, United States, 2011-2013. Emerg Infect Dis. 2014 Sep;20(9):1498-503
Scheel CM, Zhou Y, Theodoro RC, Abrams B, Balajee SA, Litvintseva AP. Development of a Loop-Mediated Isothermal Amplification Method for Detection of Histoplasma capsulatum DNA in Clinical Samples. J Clin Microbiol 2014; 52(2):483-8.
Smith RM, Mba-Jonas A, Tourdjman M, et al. Treatment and Outcomes among Patients with Cryptococcus gattii Infections in the United States Pacific Northwest. [PDF – 7 pages] PloS one. 2014;9(2):e88875.
Van Wyk M, Govender NP, Mitchell TG, Litvintseva AP, et al. Multilocus Sequence Typing of Serially Collected Isolates of Cryptococcus from HIV-Infected Patients in South Africa. J Clin Microbiol. 2014 Mar 19

Baddley JW, Andes DR, Marr KA, et al. Antifungal therapy and length of hospitalization in transplant patient with invasive aspergillosis. Med Mycol 2013; 51(2): 128-35.
Balajee SA, Hurst SF, Chang LS, et al. Multilocus sequence typing of Histoplasma capsulatum in formalin fixed paraffin-embedded tissues from cats living in non-endemic regions reveals a new phylogenetic clade. Med Mycol 2013; 51(4): 345-51.
Brandt ME, Park. BJ. Think fungus–prevention and control of fungal infections. Emerg Infect Dis 2013; 19(10): 1688-9. Podcast: http://www2c.cdc.gov/podcasts/player.asp?f=8629964
Brown J, Benedict K, Park BJ, Thompson GR, 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol 2013;5: 185-97.
Castrodale LJ, Gerlach RF, Preziosi DE, Frederickson P, Lockhart SR. Prolonged incubation period for infection with Cryptococcus gattii in an Alaska cat originally from California, 2012. Emerg Infect Dis 2013; 19: 1034-1035.
CDC. Histoplasmosis in a state where it is not known to be endemic – Montana, 2012-2013. MMWR 2013; 62(42): 834-7.
CDC. Increase in reported coccidioidomycosis–United States, 1998-2011. MMWR 2013; 62(12): 217-21.
Chiller TM, Roy M, Nguyen D, et al. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med 2013; 369(17): 1610-9.
Castrodale LJ, Gerlach RF, Preziosi DE, Frederickson P, Lockhart SR. Prolonged incubation period for infection with Cryptococcus gattii in an Alaska cat originally from California, 2012. Emerg Infect Dis 2013; 19: 1034-1035.
Escandon P, Lizarazo J, Agudelo CI, Chiller T, Castaneda E. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia. Med Mycol 2013; S1:765-768.
Espinel-Ingroff A, Arendrup MC, Pfaller MA, et al. Interlaboratory variability of caspofungin MICs for Candida species using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother 2013; 57:5836-5842.
Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010. Infect Control Hosp Epidemiol 2013;34(9).
Fanfair RN, Heslop O, Etienne K, et al. Trichosporon asahii among intensive care unit patients at a medical center in Jamaica. Infect Control Hosp Epidemiol 2013; 34(6): 638-41.
Farooqi JQ, Jabeen K, Saeed N, et al. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility. J Med Microbiol 2013; 62(Pt 2): 259-68.
Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell 2013; 12(5): 677-83.
Harris JR, Lockhart SR, Sondermeyer G, et al. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis 2013; 19(10): 1621-7.
Kunadharaju R, Choe U, Harris JR, Lockhart SR, Greene JN. Cryptococcus gattii, Florida, USA, 2011. Emerg Infect Dis 2013; 19(3): 519-21.
Lockhart SR, Iqbal N, Harris JR, et al. Cryptococcus gattii in the United States: Genotypic diversity of human and veterinary isolates. PloS one 2013; 8(9): e74737.
Lockhart SR, Pham CD, Gade L, et al. Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections. J Clin Microbiol 2013; 51(8): 2654-61.
Loyse A, Thangaraj H, Easterbrook P, et al. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis 2013; 13(7): 629-37.
Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington State. Clin Infect Dis 2013; 56(6): 847-50.
Morrison AS, Lockhart SR, Bromley JG, Kim JY, Burd EM. An environmental Sporothrix as a cause of corneal ulcer. Med Mycol Case Reports 2013; 2: 88-90.
Mortenson JA, Bartlett KH, Wilson RW, Lockhart SR. Detection of Cryptococcus gattii in Selected Urban Parks of the Willamette Valley, Oregon. Mycopathologia 2013; 175:351-355.
Nacher M, Adenis A, McDonald S, et al. Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage. PLoS Negl Trop Dis 2013; 7:e2319.
Pappas PG, Kontoyiannis DP, Perfect JR, Chiller TM. Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States. Antimicrob Agents Chemother 2013; 57(4): 1573-6.
Prandini TH, Theodoro RC, Bruder-Nascimento AC, Scheel CM, Bagagli E. Analysis of inteins in the Candida parapsilosis complex for simple and accurate species identification. J Clin Microbiol 2013; 51:2830-2836.
Purfield A, Ahmad N, Park BJ, et al. Epidemiology of commercial rhesus monkey kidney cells contaminated with Coccidioides posadasii. J Clin Microbiol 2013; 51(6): 2005.
Ritter JM, Muehlenbachs A, Blau DM, et al. Exserohilum infections associated with contaminated steroid injections: a clinicopathologic review of 40 cases. Am J Pathol 2013; 183(3): 881-92.
Rosado-Odom VM, Daoud J, Johnson R, et al. Cutaneous presentation of progressive disseminated histoplasmosis nine years after renal transplantation. Transpl Infect Dis 2013; 15:E64-69.
Roy M, Benedict K, Deak E, et al. A large community outbreak of blastomycosis in Wisconsin with geographic and ethnic clustering. Clin Infect Dis 2013; 57(5): 655-62.
Scheel CM, Hurst SF, Barreiros G, Akiti T, Nucci M, Balajee SA. Molecular analyses of Fusarium isolates recovered from a cluster of invasive mold infections in a Brazilian hospital. BMC Infect Dis 2013; 13: 49.
Smith RM, Nguyen TA, Ha HT, et al. Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program–Vietnam. PloS one 2013; 8(4): e62213.
Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013;369:1598-1609
Smith RM, Tipple M, Chaudry MN, Schaefer MK, Park BJ. Relapse of fungal meningitis associated with contaminated methylprednisolone. N Engl J Med 2013; 368(26): 2535-6.
Theodoro RC, Scheel CM, Brandt ME, Kasuga T, Bagagli E. PRP8 intein in cryptic species of Histoplasma capsulatum: evolution and phylogeny. Infect Genet Evol 2013; 18: 174-82.

Benedict K, Roy M, Chiller T, Davis JP. Epidemiologic and ecologic features of blastomycosis: a review. Curr Fung Infect Rep 2012; 6: 327-35.
Brandt ME, Lockhart SR. Recent taxonomic developments with Candida and other opportunistic yeasts. Curr Fung Infect Rep 2012; 6: 178-91.
Burco JD, Etienne KA, Massey JG, Ziccardi MH, Balajee SA. Molecular sub-typing suggests that the environment of rehabilitation centers may be a potential source of Aspergillus fumigatus infecting rehabilitating seabirds. Med Mycol 2012; 50(1): 91-8.
CDC. Histoplasmosis outbreak among day camp attendees–Nebraska, June 2012. MMWR 2012; 61: 747-8.
CDC. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy – United States, 2012. MMWR 2012; 61(41): 839-42.
Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012; 55(10): 1352-61.
Espinel-Ingroff A, Aller AI, Canton E, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother 2012; 56(11): 5898-906.
Espinel-Ingroff A, Chowdhary A, Cuenca-Estrella M, et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother 2012; 56(6): 3107-13.
Etienne KA, Gillece J, Hilsabeck R, et al. Whole genome sequence typing to investigate the Apophysomyces outbreak following a tornado in Joplin, Missouri, 2011. PloS one 2012; 7(11): e49989.
Govender NP, Chetty V, Roy M, et al. Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J 2012; 102(12): 914-7.
Harris J, Lockhart S, Chiller T. Cryptococcus gattii: where do we go from here? Med Mycol 2012; 50(2): 113-29.
Harris JR, Lindsley MD, Henchaichon S, et al. High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand [PDF – 8 pages]. Clin Infect Dis 2012; 54(5): e43-50.
Iverson SA, Chiller T, Beekmann S, Polgreen PM, Harris J. Recognition and diagnosis of Cryptococcus gattii infections in the United States. Emerg Infect Dis 2012; 18(6): 1012-5. Journal of clinical microbiology 2012; 50(6): 2040-6.
Jarvis JN, Govender N, Chiller T, et al. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care 2012; 11(6): 374-9.
Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med 2012; 367(23): 2194-203.
Klausner JD, Govender N, Oladoyinbo S, Roy M, Chiller T. Preventing AIDS deaths: cryptococcal antigen screening and treatment. Lancet Infect Dis 2012; 12(6): 431-2.
Lockhart SR, Iqbal N, Bolden CB, et al. Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis 2012; 73(2): 144-8.
Lockhart SR, Iqbal N, Cleveland AA, et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011 [PDF – 31 pages]. J Clin Microbiol 2012; 50(11): 3435-42.
Lott TJ, Frade JP, Lyon GM, Iqbal N, Lockhart SR. Bloodstream and non-invasive isolates of Candida glabrata have similar population structures and fluconazole susceptibilities. Med Mycol 2012; 50(2): 136-42.
McLeland S, Duncan C, Spraker T, Wheeler E, Lockhart SR, Gulland F. Cryptococcus albidus infection in a California sea lion (Zalophus californianus). J Wildl Dis 2012; 48(4): 1030-4.
Mortenson JA, Bartlett KH, Wilson RW, Lockhart SR. Detection of Cryptococcus gattii in selected urban parks of the Willamette Valley, Oregon. Mycopathologia 2013; 175(3-4): 351-5.
Neal CO, Deak E, Chang LS, et al. Pseudo-outbreak of Lecanicillium and Acremonium species in orthopedic surgery patients. J Clin Microbiol 2012; 50(12): 4103-6.
Neblett Fanfair R, Benedict K, Bos J, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med 2012; 367(23): 2214-25.
Olsen GL, Deitz KL, Flaherty HA, Lockhart SR, Hurst SF, Haynes JS. Use of terbinafine in the treatment protocol of intestinal Cryptococcus neoformans in a dog. J Am Anim Hosp Assoc 2012; 48(3): 216-20.
Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 2012; 50(4): 1199-203.
Pfaller MA, Castanheira M, Lockhart SR, Jones RN. Candida glabrata: Multidrug resistance and increased virulence in a major opportunistic fungal pathogen. Curr Fung Infect Rep 2012; 6: 154-64.
Pfaller MA, Espinel-Ingroff A, Canton E, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol 2012; 50(6): 2040-6.
Pham CD, Lockhart SR. An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus. Curr Fung Infect Rep 2012; 6: 288-95.
Reiss E, Lasker BA, Lott TJ, et al. Genotyping of Candida parapsilosis from three neonatal intensive care units (NICUs) using a panel of five multilocus microsatellite markers: broad genetic diversity and a cluster of related strains in one NICU. Infect Genet Evol 2012; 12(8): 1654-60.
Roy M, Harris J, Afreen S, et al. Aflatoxin contamination in food commodities in Bangladesh. Food Additives & Contamin 2012; 6(1): 1-7.
Sellers B, Hall P, Cine-Gowdie S, et al. Cryptococcus gattii: an emerging fungal pathogen in the southeastern United States. Am J Med Sci 2012; 343(6): 510-1.
Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone Injections – preliminary report. N Engl J Med 2012; Dec 19.
Vaneslow M, Brandt ME, Park BJ. Diagnosis and management of cryptococcal disease in resource-limited settings. Curr Fung Infect Rep 2012; 6: 35-40.

Baddley JW, Schain DC, Gupte AA, et al. Transmission of Cryptococcus neoformans by organ transplantation [PDF – 5 pages]. Clin Infect Dis 2011; 52(4): e94-8.
CDC. Notes from the Field: fatal fungal soft tissue infections after a tornado—Joplin, Missouri, 2011. MMWR 2011; 60(29): 992.
Chaturvedi V, Ramani R, Andes D, et al. Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrob Agents Chemother 2011; 55(4): 1543-8.
Chen S, Erhart LM, Anderson S, et al. Coccidioidomycosis: knowledge, attitudes, and practices among healthcare providers–Arizona, 2007. Med Mycol 2011; 49(6): 649-56.
Deak E, B.J. P. Cryptococcal meningitis- global public health challenges and opportunities. Eur Infect Dis 2011; 5(2): 83-7.
Deak E, Nelson M, Hernandez-Rodriguez Y, et al. Aspergillus terreus accessory conidia are multinucleated, hyperpolarizing structures that display differential dectin staining and can induce heightened inflammatory responses in a pulmonary model of aspergillosis. Virulence 2011; 2(3): 200-7.
Edupuganti S, Rouphael N, Mehta A, et al. Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification. J Clin Microbiol 2011; 49(6): 2350-3.
Engelthaler DM, Chiller T, Schupp JA, et al. Next-generation sequencing of Coccidioides immitis isolated during cluster investigation [PDF – 6 pages]. Emerg Infect Dis 2011; 17(2): 227-32.
Etienne KA, Subudhi CP, Chadwick PR, et al. Investigation of a cluster of cutaneous aspergillosis in a neonatal intensive care unit. J Hosp Infect 2011; 79(4): 344-8.
Frade JP, Arthington-Skaggs BA. Effect of serum and surface characteristics on Candida albicans biofilm formation. Mycoses 2011; 54(4): e154-62.
Gillece JD, Schupp JM, Balajee SA, et al. Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity. PloS one 2011; 6(12): e28550.
Govender NP, Chiller TM, Poonsamy B, Frean JA. Neglected fungal diseases in sub-Saharan Africa: a call to action. Curr Fung Infect Rep 2011; 5: 224-32.
Govender NP, Patel J, van Wyk M, et al. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008. Antimicrob Agents Chemother 2011; 55(6): 2606-11.
Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 2011; 24(2): 247-80.
Harris JR, Blaney DD, Lindsley MD, et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis 2011; 17(2): 268-70.
Harris JR, Lockhart SR, Debess E, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis 2011; 53(12): 1188-95.
Harris JR, Marston BJ, Sangrujee N, DuPlessis D, Park B. Cost-effectiveness analysis of diagnostic options for Pneumocystis pneumonia (PCP). PloS one 2011; 6(8): e23158.
Jabeen K, Farooqi J, Zafar A, et al. Rhinocladiella mackenziei as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Clin Infect Dis 2011; 52(2): 213-7.
Lindsley MD, Mekha N, Baggett HC, et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 2011; 53(4): 321-5.
Lockhart SR, Bolden CB, Iqbal N, Kuykendall RJ. Validation of 24-hour flucytosine MIC determination by comparison with 48-hour determination by the Clinical and Laboratory Standards Institute M27-A3 broth microdilution reference method. J Clin Microbiol 2011; 49(12): 4322-5.
Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 2011; 55(9): 4465-8.
Lockhart SR, Wagner D, Iqbal N, et al. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. J Clin Microbiol 2011; 49(7): 2404-10.
Lockhart SR, Zimbeck AJ, Baddley JW, et al. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrob Agents Chemother 2011; 55(8): 3944-6.
Lockhart SR. Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis? [PDF – 2 pages]J Clin Microbiol 2011; 49(12): 4415.
Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 2011; 17(10): 1855-64.
Park BJ, Shetty S, Ahlquist A, et al. Long-term follow-up and survival of antiretroviral-naive patients with cryptococcal meningitis in the pre-antiretroviral therapy era, Gauteng Province, South Africa. Int J STD AIDS 2011; 22(4): 199-203.
Pfaller MA, Diekema DJ, Andes D, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2011; 14(3): 164-76.
Roy M, Chiller T. Preventing death from HIV-associated cryptococcal meningitis: the way forward. Curr Fung Infect Rep 2011; 5: 206-14.
Roy M, Chiller T. Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther 2011; 9(9): 715-7.
Sharma P, Cohen JK, Lockhart SR, Hurst SF, Drew CP. Ruptured mycotic aortic aneurysm in a sooty mangabey (Cercocebus atys). Comp Med 2011; 61(6): 532-7.
Stone A, Park BJ. Penicillium marneffei infection: knowledge, gaps, and future directions. Curr Fung Infect Rep 2011; 5: 193-8.
Walraven CJ, Gerstein W, Hardison SE, et al. Fatal disseminated Cryptococcus gattii infection in New Mexico. PloS one 2011; 6(12): e28625.

Alexander BD, Schell WA, Siston AM, et al. Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts. Am J Transplant 2010; 10(9): 2161-7.
CDC. Emergence of Cryptococcus gattii— Pacific Northwest, 2004-2010. MMWR 2010; 59(28): 865-8.
Chiller TM. Fluconazole therapy for cryptococcal meningitis: are options available where it is needed most—Africa? Curr Fung Infect Rep 2010; 4: 197-9.
Da Matta DA, Melo AS, Colombo AL, Frade JP, Nucci M, Lott TJ. Candidemia surveillance in Brazil: evidence for a geographical boundary defining an area exhibiting an abatement of infections by Candida albicans group 2 strains. J Clin Microbiol 2010; 48(9): 3062-7.
Da Matta DA, Melo AS, Guimaraes T, Frade JP, Lott TJ, Colombo AL. Multilocus sequence typing of sequential Candida albicans isolates from patients with persistent or recurrent fungemia. Med Mycol 2010; 48(5): 757-62.
Deak E, Etienne KA, Lockhart SR, Gade L, Chiller T, Balajee SA. Utility of a Luminex-based assay for multiplexed, rapid species identification of Candida isolates from an ongoing candidemia surveillance. Can J Mircobiol 2010; 56(4): 348-51.
Fisher BT, Chiller TM, Prasad PA, Beveridge M, Walsh TJ, Zaoutis TE. Hospitalizations for coccidioidomycosis at forty-one children’s hospitals in the United States. Pediatr Infect Dis J 2010; 29(3): 243-7.
Garcia-Hermoso D, MacCallum DM, Lott TJ, et al. Multicenter collaborative study for standardization of Candida albicans genotyping using a polymorphic microsatellite marker. J Clin Microbiol 2010; 48(7): 2578-81.
Harris JR, Balajee SA, Park BJ. Pneumocystis jirovecii pneumonia: current knowledge and outstanding public health issues. Curr Fung Infect Rep 2010; 4: 229-37.
Iqbal N, DeBess EE, Wohrle R, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010; 48(2): 539-44.
Kim JH, Campbell BC, Mahoney N, Chan KL, Molyneux RJ, Balajee A. Augmenting the activity of antifungal agents against aspergilli using structural analogues of benzoic acid as chemosensitizing agents. Fungal Biol 2010; 114(10): 817-24.
Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50(8): 1091-100.
Lattif AA, Mukherjee PK, Chandra J, et al. Characterization of biofilms formed by Candida parapsilosis, C. metapsilosis, and C. orthopsilosis. Int J Med MIcrobiol 2010; 300(4): 265-70.
Lockhart SR, Harris JR. Cryptococcus gattii: clinical importance and emergence in North America. Curr Fung Infect Rep 2010; 4: 151-7.
Lott TJ, Frade JP, Lockhart SR. Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies. Eukaryot Cell 2010; 9(4): 619-25.
Munoz-Cadavid C, Rudd S, Zaki SR, et al. Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol 2010; 48(6): 2147-53.
O’Donnell K, Sutton DA, Rinaldi MG, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48(10): 3708-18.
Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50(8): 1101-11.
Rotstein DS, West K, Levine G, et al. Cryptococcus gattii vgi in a spinner dolphin (Stenella longirostris) from Hawaii. J Zoo Wildl Med 2010; 41(1): 181-3.
Roy M, Park BJ, Chiller TM. Donor-derived fungal infections in transplant patients. Curr Fung Infect Rep 2010; 4: 219-38.
Tsang CA, Anderson SM, Imholte SB, et al. Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008. Emerg Infect Dis 2010; 16(11): 1738-44.
Zimbeck AJ, Iqbal N, Ahlquist AM, et al. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother 2010; 54(12): 5042-7.

Baddley JW, Marr KA, Andes DR, et al. Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47(10): 3271-5.
Balajee SA, Baddley JW, Peterson SW, et al. Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell 2009; 8(5): 713-22.
Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009; 47(4): 877-84.
Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol 2009; 47(10): 3138-41.
Balajee SA.Aspergillus terreus complex. Med Mycol 2009; 47 Suppl 1: S42-6.
Brandt ME, Gade L, McCloskey CB, Balajee SA. Atypical Aspergillus flavus isolates associated with chronic azole therapy. J Clin Microbiol 2009; 47(10): 3372-5.
Burwell LA, Park BJ, Wannemuehler KA, et al. Outcomes among inmates treated for coccidioidomycosis at a correctional institution during a community outbreak, Kern County, California, 2004. Clin Infect Dis 2009; 49(11): e113-9.
CDC. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents [PDF – 216 pages]. MMWR 2009; 58(RR-4): 1-198.
CDC. Outbreak of erythema nodosum of unknown cause – New Mexico, November 2007-January 2008. MMWR 2009; 58(48): 1347-51.
Datta K, Bartlett KH, Baer R, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009; 15(8): 1185-91.
De Valk HA, Meis JF, Bretagne S, et al. Interlaboratory reproducibility of a microsatellite-based typing assay for Aspergillus fumigatus through the use of allelic ladders: proof of concept. Clin Microbiol Infect 2009; 15(2): 180-7.
Deak E, Wilson SD, White E, Carr JH, Balajee SA. Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PloS one 2009; 4(10): e7673.
Etienne KA, Gade L, Lockhart SR, et al. Screening of a large global Aspergillus fumigatus species complex collection by using a species-specific microsphere-based Luminex assay. J Clin Microbiol 2009; 47(12): 4171-2.
Etienne KA, Kano R, Balajee SA. Development and validation of a microsphere-based Luminex assay for rapid identification of clinically relevant aspergilli. J Clin Microbiol 2009; 47(4): 1096-100.
Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44(8): 489-94.
Hurst SF, Kidd SE, Morrissey CO, et al. Interlaboratory reproducibility of a single-locus sequence-based method for strain typing of Aspergillus fumigatus. J Clin Microbiol 2009; 47(5): 1562-4.
Klaassen CH, de Valk HA, Balajee SA, Meis JF. Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature. J Microbiol Methods 2009; 77(3): 292-6.
Marr KA, Bow E, Chiller T, et al. Fungal infection prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009; 44(8): 483-7.
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23(4): 525-30.
Rao CY, Pachucki C, Cali S, et al. Contaminated product water as the source of Phialemonium curvatum bloodstream infection among patients undergoing hemodialysis. Infect Control Hosp Epidemiol 2009; 30(9): 840-7.
Scheel CM, Samayoa B, Herrera A, et al. Development and evaluation of an enzyme-linked immunosorbent assay to detect Histoplasma capsulatum antigenuria in immunocompromised patients. Clinical Vaccine Immunol 2009; 16(6): 852-8.
Staab JF, Balajee SA, Marr KA. Aspergillus section Fumigati typing by PCR-restriction fragment polymorphism. J Clin Microbiol 2009; 47(7): 2079-83.
Swartzentruber S, Rhodes L, Kurkjian K, et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis 2009; 49(12): 1878-82.
Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15(10): 1143-238.
Verani JR, Lorick SA, Yoder JS, et al. National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis 2009; 15(8): 1236-42.
Warnock DW, Chiller TM, Chiller KG. Superficial fungal infections. London: Elsevier, 2009.
Winthrop KL, Chiller T. Preventing and treating biologic-associated opportunistic infections. Nat Rev Rheumatol 2009; 5(7): 405-10.

Top of Page